S.27.04 Therapeutic intervention at the mitochondrial level (Englisch)
- Neue Suche nach: Müller, W.
- Neue Suche nach: Müller, W.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
23
;
S151-S152
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:S.27.04 Therapeutic intervention at the mitochondrial level
-
Beteiligte:Müller, W. ( Autor:in )
-
Erschienen in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 23 ; S151-S152
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:S151-S152
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.8 / 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 23
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Neural networks in psychiatryHulshoff Pol, H. / Bullmore, E. et al. | 2013
- 7
-
Structure out of chaos: Functional brain network analysis with EEG, MEG, and functional MRIvan Straaten, E. C. / Stam, C. J. et al. | 2013
- 19
-
Genetic control of functional brain network efficiency in childrenvan den Heuvel, M. P. / van Soelen, I. L. / Stam, C. J. / Kahn, R. x. / Boomsma, D. I. / Hulshoff Pol, H. E. et al. | 2013
- 24
-
Decreased default network connectivity is associated with early life stress in medication-free healthy adultsPhilip, N. S. / Sweet, L. H. / Tyrka, A. R. / Price, L. H. / Bloom, R. F. / Carpenter, L. L. et al. | 2013
- 33
-
Reward circuit connectivity relates to delay discounting in children with attention-deficit/hyperactivity disorderCosta Dias, T. G. / Wilson, V. B. / Bathula, D. R. / Iyer, S. P. / Mills, K. L. / Thurlow, B. L. / Stevens, C. A. / Musser, E. D. / Carpenter, S. D. / Grayson, D. S. et al. | 2013
- 46
-
Disturbed grey matter coupling in schizophreniaCollin, G. / de Reus, M. A. / Cahn, W. / Hulshoff Pol, H. E. / Kahn, R. x. / van den Heuvel, M. P. et al. | 2013
- 55
-
Brain, networks, depression, and moreLeistedt, S. x. / Linkowski, P. et al. | 2013
- 63
-
Structural networks in Alzheimer's diseaseReid, A. T. / Evans, A. C. et al. | 2013
- 79
-
Testosterone in the brain: Neuroimaging findings and the potential role for neuropsychopharmacologyHö / fer, P. / Lanzenberger, R. / Kasper, S. et al. | 2013
- 89
-
Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European UnionRehm, J. / Shield, K. D. / Gmel, G. / Rehm, M. X. / Frick, U. et al. | 2013
- 98
-
Burden of psychiatric disorders in the pediatric populationClavenna, A. / Cartabia, M. / Sequi, M. / Costantino, M. A. / Bortolotti, A. / Fortino, I. / Merlino, L. / Bonati, M. et al. | 2013
- 107
-
Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humansHoch, M. / Hay, J. L. / Hoever, P. / de Kam, M. L. / te Beek, E. T. / van Gerven, J. M. / Dingemanse, J. et al. | 2013
- 118
-
Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysisSoares-Weiser, K. / Bé / chard-Evans, L. / Howard Lawson, A. / Davis, J. / Ascher-Svanum, H. et al. | 2013
- 126
-
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosisBloemen, O. J. / de Koning, M. B. / Gleich, T. / Meijer, J. / de Haan, L. / Linszen, D. H. / Booij, J. / van Amelsvoort, T. x. et al. | 2013
- 133
-
Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—A rat microdialysis and electrophysiology studyPehrson, A. L. / Cremers, T. / Bé / try, C. / van der Hart, M. G. / Jø / rgensen, L. / Madsen, M. / Haddjeri, N. / Ebert, B. et al. | 2013
- 146
-
Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuitGuegan, T. / Cutando, L. / Ayuso, E. / Santini, E. / Fisone, G. / Bosch, F. / Martinez, A. / Valjent, E. / Maldonado, R. / Martin, M. et al. | 2013
- 160
-
Comparison of the long-term consequences of withdrawal from repeated amphetamine exposure in adolescence and adulthood on information processing and locomotor sensitization in miceRichetto, J. / Feldon, J. / Riva, M. A. / Meyer, U. et al. | 2013
- 171
-
Antidepressants act directly on astrocytes: Evidences and functional consequencesCzé / h, B. x. / Di Benedetto, B. et al. | 2013
- 186
-
Resting-state functional connectivity abnormalities in limbic and salience networks in social anxiety disorder without comorbidityPannekoek, J. N. / Veer, I. M. / van Tol, M. J. / van der Werff, S. J. / Demenescu, L. R. / Aleman, A. x. / Veltman, D. J. / Zitman, F. G. / Rombouts, S. A. / van der Wee, N. J. et al. | 2013
- 196
-
Persistent negative symptoms in first episode patients with schizophrenia: Results from the European First Episode Schizophrenia TrialGalderisi, S. / Mucci, A. / Bitter, I. / Libiger, J. / Bucci, P. / Wolfgang Fleischhacker, W. / Kahn, R. x. / for, t. E. et al. | 2013
- 205
-
Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugsManu, P. / Correll, C. U. / Wampers, M. / van Winkel, R. / Yu, W. / Mitchell, A. J. / De Hert, M. et al. | 2013
- 212
-
Chronic use of benzodiazepines and latent cognitive decline in the elderly: Results from the Three-city studyMura, T. / Proust-Lima, C. x. / Akbaraly, T. / Amieva, H. x. / Tzourio, C. / Chevassus, H. / Picot, M. C. / Jacqumin-Gadda, H. x. / Berr, C. et al. | 2013
- 224
-
Finite mixture regression model analysis on antipsychotics induced weight gain: Investigation of the role of the serotonergic genesNowrouzi, B. / Souza, R. P. / Zai, C. / Shinkai, T. / Monda, M. / Lieberman, J. / Volvaka, J. / Meltzer, H. Y. / Kennedy, J. L. / De Luca, V. et al. | 2013
- 229
-
Chronic effects of corticosterone on GIRK1-3 subunits and 5-HT1A receptor expression in rat brain and their reversal by concurrent fluoxetine treatmentSaenz del Burgo, L. / Corté / s, R. / Mengod, G. / Montañ / a, M. / Garcí / a del Cañ / o, G. / Sallé et al. | 2013
- 240
-
Operant behavior to obtain palatable food modifies ERK activity in the brain reward circuitGuegan, T. / Cutando, L. / Gangarossa, G. / Santini, E. / Fisone, G. / Martinez, A. / Valjent, E. / Maldonado, R. / Martin, M. et al. | 2013
- 253
-
PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophreniaBeyaert, M. G. / Daya, R. P. / Dyck, B. A. / Johnson, R. L. / Mishra, R. K. et al. | 2013
- 263
-
Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: A principal component analysis of lifetime pharmacological and biophysic treatment optionsNivoli, A. M. / Colom, F. / Pacchiarotti, I. / Murru, A. / Scott, J. / Valentí / M. / Mazzarini, L. / del Mar Bonnin, C. / Sá et al. | 2013
- 276
-
A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GADAbdallah, C. G. / Coplan, J. D. / Jackowski, A. / Sato, J. x. / Mao, X. / Shungu, D. C. / Mathew, S. J. et al. | 2013
- 285
-
Prefrontal serotonin transporter availability is positively associated with the cortisol awakening responseFrokjaer, V. G. / Erritzoe, D. / Holst, K. K. / Jensen, P. S. / Rasmussen, P. M. / Fisher, P. M. / Baaré / W. / Madsen, K. S. / Madsen, J. et al. | 2013
- 295
-
Tract-based diffusion tensor imaging in patients with schizophrenia and their non-psychotic siblingsBoos, H. B. / Mandl, R. x. / van Haren, N. E. / Cahn, W. / van Baal, G. C. / Kahn, R. x. / Hulshoff Pol, H. E. et al. | 2013
- 305
-
Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute maniaGoikolea, J. M. / Colom, F. / Capapey, J. / Torres, I. / Valenti, M. / Grande, I. / Undurraga, J. / Vieta, E. et al. | 2013
- 317
-
Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorderPandolfo, P. / Machado, N. J. / Kö / falvi, A. / Takahashi, R. N. / Cunha, R. A. et al. | 2013
- 329
-
Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studiesMas, S. / Gassó / P. / Bernardo, M. / Lafuente, A. et al. | 2013
- 338
-
Clozapine resistance—Augmentation strategiesTiihonen, J. / Leucht, S. et al. | 2013
- 339
-
Effects of a small dose of olanzapine on healthy subjects according to their schizotypy: An ERP study using a semantic categorization and an oddball taskDebruille, J. B. / Rodier, M. / Pré / vost, M. / Lionnet, C. / Molavi, S. et al. | 2013
- 351
-
The relationship between lifetime stress and addiction severity in cocaine-dependent participantsMahoney, J. J. / Newton, T. F. / Omar, Y. / Ross, E. L. / De La Garza, R. et al. | 2013
- 358
-
Interactive effects of corticotropin-releasing hormone receptor 1 gene and childhood adversity on depressive symptoms in young adults: Findings from a longitudinal studyLaucht, M. / Treutlein, J. / Blomeyer, D. / Buchmann, A. F. / Schmidt, M. H. / Esser, G. x. / Jennen-Steinmetz, C. / Rietschel, M. / Banaschewski, T. et al. | 2013
- 368
-
Acute pharmacologically induced shifts in serotonin availability abolish emotion-selective responses to negative face emotions in distinct brain networksGrady, C. L. / Siebner, H. R. / Hornboll, B. / Macoveanu, J. / Paulson, O. B. / Knudsen, G. M. et al. | 2013
- 379
-
Conditioned fear response is modulated by a combined action of the hypothalamic–pituitary–adrenal axis and dopamine activity in the basolateral amygdalade Oliveira, A. R. / Reimer, A. E. / Reis, F. M. / Brandã / o, M. L. et al. | 2013
- 390
-
Benzodiazepine-induced spatial learning deficits in rats are regulated by the degree of modulation of α1 GABAA receptorsJoksimović / S. x. / Divljaković / J. / Van Linn, M. L. / Varagic, Z. / Brajković / G. / Milinković / M. M. et al. | 2013
- 400
-
Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine–nitric oxide–cyclic guanosine monophosphate pathway and increases BDNF levelsLudka, F. K. / Zomkowski, A. x. / Cunha, M. P. / Dal-Cim, T. / Zeni, A. L. / Rodrigues, A. L. / Tasca, C. I. et al. | 2013
- 413
-
IMpACTing on adult ADHD researchFranke, B. / Reif, A. et al. | 2013
- 416
-
Genetic associations between the ADHD symptom dimensions and Cloninger's temperament dimensions in adult twinsMerwood, A. / Asherson, P. / Larsson, H. et al. | 2013
- 426
-
Evaluation of common variants in 16 genes involved in the regulation of neurotransmitter release in ADHDSá / nchez-Mora, C. / Cormand, B. / Ramos-Quiroga, J. A. / Hervá / s, A. / Bosch, R. / Palomar, G. x. / Nogueira, M. / Gó et al. | 2013
- 436
-
KCNIP4 as a candidate gene for personality disorders and adult ADHDWeiß / flog, L. / Scholz, C. J. / Jacob, C. P. / Nguyen, T. T. / Zamzow, K. / Groß / Renner, T. J. / Romanos, M. / Rujescu, D. et al. | 2013
- 448
-
Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: A pilot study of six candidate genesCarpentier, P. J. / Arias Vasquez, A. / Hoogman, M. / Onnink, M. / Kan, C. C. / Kooij, J. J. / Makkinje, R. / Iskandar, S. / Kiemeney, L. A. / de Jong, C. A. et al. | 2013
- 458
-
Influence of a Latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD)Fallgatter, A. J. / Ehlis, A. C. / Dresler, T. / Reif, A. / Jacob, C. P. / Arcos-Burgos, M. / Muenke, M. / Lesch, K. P. et al. | 2013
- 469
-
The dopamine transporter haplotype and reward-related striatal responses in adult ADHDHoogman, M. / Onnink, M. / Cools, R. / Aarts, E. / Kan, C. / Arias Vasquez, A. / Buitelaar, J. / Franke, B. et al. | 2013
- 479
-
Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHDLesch, K. P. / Merker, S. / Reif, A. / Novak, M. et al. | 2013
- 492
-
Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networksRivero, O. / Sich, S. / Popp, S. / Schmitt, A. / Franke, B. / Lesch, K. P. et al. | 2013
- 508
-
Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studiesFredriksen, M. / Halmø / y, A. / Faraone, S. V. / Haavik, J. et al. | 2013
- 528
-
Do stimulants improve functioning in adults with ADHD?:A review of the literatureSurman, C. B. / Hammerness, P. G. / Pion, K. / Faraone, S. V. et al. | 2013
- 534
-
Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adultsMick, E. / McManus, D. D. / Goldberg, R. J. et al. | 2013
- 542
-
Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort studyBron, T. I. / Bijlenga, D. / Kasander, M. V. / Spuijbroek, A. T. / Beekman, A. T. / Kooij, J. J. et al. | 2013
- 555
-
Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): A systematic reviewContini, V. x. / Rovaris, D. L. / Victor, M. M. / Grevet, E. H. / Rohde, L. A. / Bau, C. H. et al. | 2013
- 561
-
Manifesto for a European research network into obsessive-compulsive and related disordersFineberg, N. A. / Baldwin, D. S. / Menchon, J. M. / Denys, D. / Grü / nblatt, E. / Pallanti, S. / Stein, D. J. / Zohar, J. et al. | 2013
- 569
-
Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorderHoexter, M. Q. / Dougherty, D. D. / Shavitt, R. G. / D'Alcante, C. C. / Duran, F. L. / Lopes, A. C. / Diniz, J. B. / Batistuzzo, M. C. / Evans, K. C. / Bressan, R. A. et al. | 2013
- 581
-
Widespread changes of white matter microstructure in obsessive–compulsive disorder: Effect of drug statusBenedetti, F. / Giacosa, C. / Radaelli, D. / Poletti, S. / Pozzi, E. / Dallaspezia, S. / Falini, A. / Smeraldi, E. et al. | 2013
- 594
-
Trajectory in obsessive-compulsive disorder comorbiditiesde Mathis, M. A. / Diniz, J. B. / Hounie, A. G. / Shavitt, R. G. / Fossaluza, V. / Ferrã / o, Y. / Leckman, J. F. / de Braganç / a Pereira, C. et al. | 2013
- 602
-
Blood microRNA changes in depressed patients during antidepressant treatmentBocchio-Chiavetto, L. / Maffioletti, E. / Bettinsoli, P. / Giovannini, C. / Bignotti, S. / Tardito, D. / Corrada, D. / Milanesi, L. / Gennarelli, M. et al. | 2013
- 612
-
Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR⁎DFabbri, C. / Drago, A. / Serretti, A. et al. | 2013
- 622
-
Hippocampal volume and internalizing behavior problems in adolescenceKoolschijn, P. C. / van IJzendoorn, M. H. / Bakermans-Kranenburg, M. J. / Crone, E. A. et al. | 2013
- 629
-
Influence of catechol-O-methyltransferase Val158Met polymorphism on startle response in the presence of high estradiol levelsComasco, E. / Hellgren, C. / Sundströ / m-Poromaa, I. et al. | 2013
- 636
-
Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: A randomized, double-blind, placebo-controlled trialMozaffari-Khosravi, H. / Yassini-Ardakani, M. / Karamati, M. / Shariati-Bafghi, S. E. et al. | 2013
- 645
-
The effect of 6-week treatment with escitalopram on CCK-4 challenge: A placebo-controlled study in CCK-4-sensitive healthy volunteersTõ / ru, I. / Maron, E. / Raag, M. / Vasar, V. / Nutt, D. J. / Shlik, J. et al. | 2013
- 653
-
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levelsKloiber, S. / Ripke, S. / Kohli, M. A. / Reppermund, S. / Salyakina, D. / Uher, R. / McGuffin, P. / Perlis, R. H. / Hamilton, S. P. / Pü et al. | 2013
- 663
-
Genetics of emergent suicidality during antidepressive treatment—Data from a naturalistic study on a large sample of inpatients with a major depressive episodeMusil, R. / Zill, P. / Seemü / ller, F. / Bondy, B. / Meyer, S. / Spellmann, I. / Bender, W. / Adli, M. / Heuser, I. et al. | 2013
- 675
-
Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: A randomised controlled trial in patients with schizophrenia and healthy controlsScheewe, T. W. / van Haren, N. E. / Sarkisyan, G. / Schnack, H. G. / Brouwer, R. M. / de Glint, M. / Hulshoff Pol, H. E. / Backx, F. J. / Kahn, R. x. / Cahn, W. et al. | 2013
- 686
-
Psychiatrists' decision making between branded and generic drugsHamann, J. / Mendel, R. / Kissling, W. / Leucht, S. et al. | 2013
- 691
-
mGluR5 is necessary for maintenance of methamphetamine-induced associative learningHerrold, A. A. / Voigt, R. M. / Napier, T. C. et al. | 2013
- 697
-
Social vs. environmental stress models of depression from a behavioural and neurochemical approachVenzala, E. / Garcí / a-Garcí / a, A. L. / Elizalde, N. / Tordera, R. M. et al. | 2013
- 709
-
Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapineBjö / rkholm, C. / Jardemark, K. / Marcus, M. M. / Malmerfelt, A. / Nyberg, S. / Schilströ / m, B. x. / Svensson, T. H. et al. | 2013
- 721
-
P50 sensory gating is a trait marker of the bipolar spectrumCabranes, J. x. / Ancí / n, I. x. / Santos, J. x. / Sá / nchez-Morla, E. / Garcí / a-Jimé / nez, M. x. / Rodrí et al. | 2013
- 728
-
Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitorXue, R. / Jin, Z. L. / Chen, H. X. / Yuan, L. / He, X. H. / Zhang, Y. P. / Meng, Y. G. / Xu, J. P. / Zheng, J. Q. / Zhong, B. H. et al. | 2013
- 742
-
The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addictionEffertz, T. / Mann, K. et al. | 2013
- 749
-
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophreniaCosta, M. / Squassina, A. / Congiu, D. / Chillotti, C. / Niola, P. / Galderisi, S. / Pistis, M. / Del Zompo, M. et al. | 2013
- 760
-
Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptorsFranklin, J. M. / Vasiljevik, T. / Prisinzano, T. E. / Carrasco, G. A. et al. | 2013
- 769
-
Cognition in schizophrenia: Summary Nice Consultation Meeting 2012Nutt, D. / Gispen-de Wied, C. C. / Arango, C. / Keefe, R. S. / Penadés, R. / Murphy, D. G. / Robbins, T. W. / Sahakian, B. J. et al. | 2013
- 779
-
Finally: A focus on cognition in schizophreniaKahn, R. S. et al. | 2013
- 781
-
Commentary on “Cognition in schizophrenia”Harvey, P. D. et al. | 2013
- 784
-
Commentary on “Regulatory issues in drug development programs targeting cognitive impairment in schizophrenia”Laughren, T. et al. | 2013
- 788
-
Comment on “Cognition in Schizophrenia: Summary Nice Consultation Meeting 2012”Goldberg, T. E. / Gomar, J. J. et al. | 2013
- 790
-
Treating impaired cognition in schizophrenia: The case for combining cognitive-enhancing drugs with cognitive remediationMichalopoulou, P. G. / Lewis, S. n. / Wykes, T. / Jaeger, J. / Kapur, S. et al. | 2013
- 799
-
The potential role of dopamine D3 receptor neurotransmission in cognitionNakajima, S. / Gerretsen, P. / Takeuchi, H. / Caravaggio, F. / Chow, T. / Le Foll, B. / Mulsant, B. / Pollock, B. / Graff-Guerrero, A. et al. | 2013
- 814
-
The efficacy of agomelatine in previously-treated depressed patientsKasper, S. / Hajak, G. r. et al. | 2013
- 822
-
Reduced post-synaptic serotonin type 1A receptor binding in bipolar depressionNugent, A. C. / Bain, E. E. / Carlson, P. J. / Neumeister, A. / Bonne, O. / Carson, R. E. / Eckelman, W. / Herscovitch, P. / Zarate, C. A. / Charney, D. S. et al. | 2013
- 830
-
The role of 5-HT in response inhibition and re-engagementDrueke, B. / Schlaegel, S. M. / Seifert, A. / Moeller, O. / Gründer, G. / Gauggel, S. / Boecker, M. et al. | 2013
- 842
-
Early prediction of clinical and functional outcome in schizophreniaAgid, O. / Siu, C. O. / Pappadopulos, E. / Vanderburg, D. / Remington, G. et al. | 2013
- 852
-
Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjectsMuguruza, C. / Moreno, J. L. / Umali, A. / Callado, L. F. / Meana, J. J. / González-Maeso, J. et al. | 2013
- 865
-
The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS)Dell'Osso, B. / Benatti, B. / Buoli, M. / Altamura, A. C. / Marazziti, D. / Hollander, E. / Fineberg, N. / Stein, D. J. / Pallanti, S. / Nicolini, H. et al. | 2013
- 872
-
Schizophrenia, antipsychotics and risk of hip fracture: A population-based analysisSørensen, H. J. / Jensen, S. O. / Nielsen, J. et al. | 2013
- 879
-
The cost of mental disorders in FranceChevreul, K. / Prigent, A. l. / Bourmaud, A. l. / Leboyer, M. / Durand-Zaleski, I. et al. | 2013
- 887
-
AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatmentDrago, A. / Giegling, I. / Schäfer, M. / Hartmann, A. M. / Friedl, M. / Konte, B. / Möller, H. J. / De Ronchi, D. / Stassen, H. H. / Serretti, A. et al. | 2013
- 895
-
Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorderAmital, D. / Fostick, L. / Silberman, A. / Calati, R. / Spindelegger, C. / Serretti, A. / Juven-Wetzler, A. / Souery, D. / Mendlewicz, J. / Montgomery, S. et al. | 2013
- 902
-
BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: A prospective studyBuchmann, A. F. / Hellweg, R. / Rietschel, M. / Treutlein, J. / Witt, S. H. / Zimmermann, U. S. / Schmidt, M. H. / Esser, G. n. / Banaschewski, T. / Laucht, M. et al. | 2013
- 910
-
The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: A report of gender differencesBloch, M. / Meiboom, H. / Zaig, I. / Schreiber, S. / Abramov, L. et al. | 2013
- 919
-
Playing it safe but losing anyway—Serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversionMacoveanu, J. / Rowe, J. B. / Hornboll, B. / Elliott, R. / Paulson, O. B. / Knudsen, G. M. / Siebner, H. R. et al. | 2013
- 931
-
Glycine treatment of the risk syndrome for psychosis: Report of two pilot studiesWoods, S. W. / Walsh, B. C. / Hawkins, K. A. / Miller, T. J. / Saksa, J. R. / D'Souza, D. C. / Pearlson, G. D. / Javitt, D. C. / McGlashan, T. H. / Krystal, J. H. et al. | 2013
- 941
-
The DRD2 C957T polymorphism and the Attentional Blink—A genetic association studyFelten, A. / Montag, C. / Kranczioch, C. / Markett, S. / Walter, N. T. / Reuter, M. et al. | 2013
- 948
-
Effect of modafinil on impulsivity and relapse in alcohol dependent patients: A randomized, placebo-controlled trialJoos, L. / Goudriaan, A. E. / Schmaal, L. / Fransen, E. / van den Brink, W. / Sabbe, B. G. / Dom, G. et al. | 2013
- 956
-
Equipercentile linking of the BPRS and the PANSSLeucht, S. / Rothe, P. / Davis, J. M. / Engel, R. R. et al. | 2013
- 960
-
Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivoKaushal, N. / Seminerio, M. J. / Robson, M. J. / McCurdy, C. R. / Matsumoto, R. R. et al. | 2013
- 972
-
Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: Studies with a mouse model of parkinsonian tremorSalamone, J. D. / Collins-Praino, L. E. / Pardo, M. / Podurgiel, S. J. / Baqi, Y. / Müller, C. E. / Schwarzschild, M. A. / Correa, M. et al. | 2013
- 978
-
Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrierMenga, A. / Infantino, V. / Iacobazzi, F. / Convertini, P. / Palmieri, F. / Iacobazzi, V. et al. | 2013
- 988
-
Cholinergic gating of hippocampal auditory evoked potentials in freely moving ratsKlinkenberg, I. / Sambeth, A. / Blokland, A. et al. | 2013
- 999
-
Schizophrenia and dopamine receptorsSeeman, P. et al. | 2013
- 1010
-
The impact of trial characteristics on premature discontinuation of antipsychotics in schizophreniaSpineli, L. M. / Leucht, S. / Cipriani, A. / Higgins, J. P. / Salanti, G. et al. | 2013
- 1017
-
Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switchingAgid, O. / Schulze, L. / Arenovich, T. / Sajeev, G. / McDonald, K. / Foussias, G. / Fervaha, G. / Remington, G. et al. | 2013
- 1023
-
Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trialsDold, M. / Li, C. / Gillies, D. / Leucht, S. et al. | 2013
- 1034
-
Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substancesSchulze, J. / van den Bussche, H. / Glaeske, G. / Kaduszkiewicz, H. / Wiese, B. / Hoffmann, F. et al. | 2013
- 1043
-
Does early improvement predict response to the fast-dissociating D2 receptor antagonist JNJ-37822681 in patients with acute schizophrenia?Anghelescu, I. G. / Janssens, L. / Kent, J. / de Boer, P. / Tritsmans, L. / Daly, E. J. / van Nueten, L. / Schmidt, M. E. et al. | 2013
- 1051
-
Psychometric analysis in support of shortening the Scale for the Assessment of Negative SymptomsLevine, S. Z. / Leucht, S. et al. | 2013
- 1057
-
Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: A randomized controlled superiority trialRubio-Valera, M. / March Pujol, M. / Fernández, A. / Peñarrubia-María, M. T. / Travé, P. / López del Hoyo, Y. / Serrano-Blanco, A. et al. | 2013
- 1067
-
Nanopsychiatry—The potential role of nanotechnologies in the future of psychiatry: A systematic reviewFond, G. / Macgregor, A. / Miot, S. et al. | 2013
- 1072
-
Validation of an abbreviated quality of life scale for schizophreniaFervaha, G. / Remington, G. et al. | 2013
- 1078
-
Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinenceCorominas-Roso, M. / Roncero, C. / Eiroa-Orosa, F. J. / Gonzalvo, B. a. / Grau-Lopez, L. / Ribases, M. / Rodriguez-Cintas, L. / Sánchez-Mora, C. / Ramos-Quiroga, J. A. / Casas, M. et al. | 2013
- 1085
-
Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the ratShortall, S. E. / Macerola, A. E. / Swaby, R. T. / Jayson, R. / Korsah, C. / Pillidge, K. E. / Wigmore, P. M. / Ebling, F. J. / Richard Green, A. / Fone, K. C. et al. | 2013
- 1096
-
Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptorGomes, F. V. / Alves, F. H. / Guimarães, F. S. / Correa, F. M. / Resstel, L. B. / Crestani, C. C. et al. | 2013
- 1105
-
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram responsePowell, T. R. / Schalkwyk, L. C. / Heffernan, A. L. / Breen, G. / Lawrence, T. / Price, T. / Farmer, A. E. / Aitchison, K. J. / Craig, I. W. / Danese, A. et al. | 2013
- 1115
-
Mesenchymal stem cells protect from sub-chronic phencyclidine insult in vivo and counteract changes in astrocyte gene expression in vitroBarzilay, R. / Ganz, J. / Sadan, O. / Ben-Zur, T. / Bren, Z. / Hinden, N. / Taler, M. / Lev, N. / Gil-Ad, I. / Weizman, A. et al. | 2013
- 1125
-
Serotonergic genes and suicide: A systematic reviewAntypa, N. / Serretti, A. / Rujescu, D. et al. | 2013
- 1143
-
Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatmentCrawford, A. A. / Lewis, G. / Lewis, S. J. / Munafò, M. R. et al. | 2013
- 1151
-
MR imaging of the effects of methylphenidate on brain structure and function in Attention-Deficit/Hyperactivity DisorderSchweren, L. J. / de Zeeuw, P. / Durston, S. et al. | 2013
- 1165
-
The hippocampal–prefrontal pathway: The weak link in psychiatric disorders?Godsil, B. P. / Kiss, J. P. / Spedding, M. / Jay, T. r. et al. | 2013
- 1182
-
Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targetsGong, Y. / Wu, C. N. / Xu, J. / Feng, G. / Xing, Q. H. / Fu, W. / Li, C. / He, L. / Zhao, X. Z. et al. | 2013
- 1190
-
5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjectsStenkrona, P. / Halldin, C. / Lundberg, J. et al. | 2013
- 1199
-
Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patientsStelzhammer, V. / Guest, P. C. / Rothermundt, M. / Sondermann, C. / Michael, N. / Schwarz, E. / Rahmoune, H. / Bahn, S. et al. | 2013
- 1208
-
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorderCoghill, D. / Banaschewski, T. / Lecendreux, M. / Soutullo, C. / Johnson, M. / Zuddas, A. / Anderson, C. / Civil, R. / Higgins, N. / Lyne, A. et al. | 2013
- 1219
-
l-Acetylcarnitine in dysthymic disorder in elderly patients: A double-blind, multicenter, controlled randomized study vs. fluoxetineBersani, G. / Meco, G. / Denaro, A. / Liberati, D. / Colletti, C. / Nicolai, R. / Bersani, F. S. / Koverech, A. et al. | 2013
- 1226
-
Vulnerability versus resilience to prenatal stress in male and female rats; Implications from gene expression profiles in the hippocampus and frontal cortexVan den Hove, D. L. / Kenis, G. / Brass, A. / Opstelten, R. / Rutten, B. P. / Bruschettini, M. / Blanco, C. E. / Lesch, K. P. / Steinbusch, H. W. / Prickaerts, J. et al. | 2013
- 1247
-
The role of dopamine in inhibitory control in smokers and non-smokers: A pharmacological fMRI studyLuijten, M. / Veltman, D. J. / Hester, R. / Smits, M. / Nijs, I. M. / Pepplinkhuizen, L. / Franken, I. H. et al. | 2013
- 1257
-
Subjective well-being in schizophrenia: A randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER)Naber, D. / Peuskens, J. / Schwarzmann, N. / Goltz, M. / Krüger, H. / Lambert, M. / Maria Haro, J. et al. | 2013
- 1270
-
Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin usersPreller, K. H. / Wagner, M. / Sulzbach, C. / Hoenig, K. / Neubauer, J. / Franke, P. E. / Petrovsky, N. / Frommann, I. / Rehme, A. K. / Quednow, B. B. et al. | 2013
- 1280
-
CSF 5-HIAA, cortisol and DHEAS levels in suicide attemptersChatzittofis, A. / Nordström, P. / Hellström, C. / Arver, S. / Åsberg, M. / Jokinen, J. et al. | 2013
- 1288
-
Oxytocin effects on complex brain networks are moderated by experiences of maternal love withdrawalRiem, M. M. / van IJzendoorn, M. H. / Tops, M. / Boksem, M. A. / Rombouts, S. A. / Bakermans-Kranenburg, M. J. et al. | 2013
- 1296
-
A modified Drug Attitude Inventory used in long-term patients in sheltered housingStjernswärd, S. / Persson, K. / Nielsen, R. / Tuninger, E. / Levander, S. et al. | 2013
- 1300
-
Three-way interaction effect of 5-HTTLPR, BDNF Val66Met, and childhood adversity on depression: A replication studyComasco, E. / Åslund, C. / Oreland, L. / Nilsson, K. W. et al. | 2013
- 1307
-
Why negative meta-analyses may be false?Hajek, T. / Kopecek, M. / Alda, M. / Uher, R. / Höschl, C. et al. | 2013
- 1310
-
Haloperidol modulates midbrain-prefrontal functional connectivity in the rat brainGass, N. / Schwarz, A. J. / Sartorius, A. / Cleppien, D. / Zheng, L. / Schenker, E. / Risterucci, C. / Meyer-Lindenberg, A. / Weber-Fahr, W. et al. | 2013
- 1320
-
Footshock-induced responses in ventral subiculum neurons are mediated by locus coeruleus noradrenergic afferentsLipski, W. J. / Grace, A. A. et al. | 2013
- 1329
-
Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT1A, but not 5-HT2 receptor activationStancampiano, R. / Frau, R. / Bini, V. / Collu, M. / Carta, M. / Fadda, F. / Bortolato, M. et al. | 2013
- 1337
-
The increasing burden of mental and neurological disordersCatalá-López, F. n. / Gènova-Maleras, R. / Vieta, E. / Tabarés-Seisdedos, R. et al. | 2013
- 1340
-
International comparative performance of mental health research, 1980–2011Larivière, V. / Diepeveen, S. / Ni Chonaill, S. o. / Macaluso, B. t. / Pollitt, A. / Grant, J. et al. | 2013
- 1348
-
A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorderChitty, K. M. / Lagopoulos, J. / Lee, R. S. / Hickie, I. B. / Hermens, D. F. et al. | 2013
- 1364
-
Intoxications with the monoamine oxidase inhibitor tranylcypromine: An analysis of fatal and non-fatal eventsGahr, M. / Schönfeldt-Lecuona, C. / Kölle, M. A. / Freudenmann, R. W. et al. | 2013
- 1373
-
Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extensionHarvey, P. D. / Siu, C. O. / Hsu, J. / Cucchiaro, J. / Maruff, P. / Loebel, A. et al. | 2013
- 1383
-
Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: A nationwide study in HungaryBitter, I. n. / Katona, L. / Zámbori, J. n. / Takács, P. t. / Fehér, L. s. / Diels, J. / Bacskai, M. s. / Lang, Z. / Gyáni, G. / Czobor, P. l. et al. | 2013
- 1391
-
The cardiovascular safety profile of escitalopramThase, M. E. / Larsen, K. G. / Reines, E. / Kennedy, S. H. et al. | 2013
- 1401
-
Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and α1A-adrenoceptor gene variationShorter, D. / Nielsen, D. A. / Huang, W. / Harding, M. J. / Hamon, S. C. / Kosten, T. R. et al. | 2013
- 1408
-
Fluorescence of neutrophil granulocytes as a biomarker for clozapine useMan, W. H. / ten Berg, M. / Wilting, I. / Huisman, A. / Cahn, W. / Douma, J. W. / den Breeijen, H. / Heerdink, E. R. / Egberts, T. / van Solinge, W. et al. | 2013
- 1414
-
Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the ratGastambide, F. / Mitchell, S. N. / Robbins, T. W. / Tricklebank, M. D. / Gilmour, G. et al. | 2013
- 1423
-
Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorderDenys, D. / de Vries, F. / Cath, D. / Figee, M. / Vulink, N. / Veltman, D. J. / van der Doef, T. F. / Boellaard, R. / Westenberg, H. / van Balkom, A. et al. | 2013
- 1432
-
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependenceGual, A. / He, Y. / Torup, L. / van den Brink, W. / Mann, K. et al. | 2013
- 1443
-
Side effects of antidepressants during long-term use in a naturalistic settingBet, P. M. / Hugtenburg, J. G. / Penninx, B. W. / Hoogendijk, W. J. et al. | 2013
- 1452
-
Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patientsJiménez, E. / Arias, B. / Mitjans, M. / Goikolea, J. M. / Roda, E. / Sáiz, P. A. / García-Portilla, M. P. / Burón, P. / Bobes, J. / Oquendo, M. A. et al. | 2013
- 1463
-
Evaluation of single nucleotide polymorphisms in the miR-183–96–182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs)Sánchez-Mora, C. / Ramos-Quiroga, J. A. / Garcia-Martínez, I. / Fernàndez-Castillo, N. / Bosch, R. / Richarte, V. / Palomar, G. / Nogueira, M. / Corrales, M. / Daigre, C. et al. | 2013
- 1474
-
Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuliGingnell, M. / Bannbers, E. / Wikström, J. / Fredrikson, M. / Sundström-Poromaa, I. et al. | 2013
- 1484
-
Glutamate changes in healthy young adulthoodMarsman, A. / Mandl, R. C. / van den Heuvel, M. P. / Boer, V. O. / Wijnen, J. P. / Klomp, D. W. / Luijten, P. R. / Hilleke E., H. P. et al. | 2013
- 1491
-
Monoaminergic dysfunction in recreational users of dexamphetamineSchouw, M. L. / Caan, M. W. / Geurts, H. M. / Schmand, B. / Booij, J. / Nederveen, A. J. / Reneman, L. et al. | 2013
- 1503
-
Prediction of antidepressant treatment response from gray matter volume across diagnostic categoriesSämann, P. G. / Höhn, D. / Chechko, N. / Kloiber, S. / Lucae, S. / Ising, M. / Holsboer, F. / Czisch, M. et al. | 2013
- 1516
-
Imaging brain gene expression profiles by antipsychotics: Region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidolde Bartolomeis, A. / Marmo, F. / Buonaguro, E. F. / Rossi, R. / Tomasetti, C. / Iasevoli, F. et al. | 2013
- 1530
-
Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: Implications for the serotonergic systemBrunoni, A. R. / Kemp, A. H. / Shiozawa, P. / Cordeiro, Q. / Valiengo, L. C. / Goulart, A. C. / Coprerski, B. / Lotufo, P. A. / Brunoni, D. / Perez, A. B. et al. | 2013
- 1541
-
Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depressionKayser, S. / Bewernick, B. H. / Hurlemann, R. / Soehle, M. / Schlaepfer, T. E. et al. | 2013
- 1551
-
Acute anxiolytic effects of quetiapine during virtual reality exposure—A double-blind placebo-controlled trial in patients with specific phobiaDiemer, J. / Domschke, K. / Mühlberger, A. / Winter, B. / Zavorotnyy, M. / Notzon, S. / Silling, K. / Arolt, V. / Zwanzger, P. et al. | 2013
- 1561
-
Auditory P3 in antidepressant pharmacotherapy treatment responders, non-responders and controlsJaworska, N. / De Somma, E. / Blondeau, C. / Tessier, P. / Norris, S. / Fusee, W. / Smith, D. / Blier, P. / Knott, V. et al. | 2013
- 1570
-
A latent variable approach in simultaneous modeling of longitudinal and dropout data in schizophrenia trialsGoyal, N. / Gomeni, R. et al. | 2013
- 1577
-
Dopaminergic modulation of the reward system in schizophrenia: A placebo-controlled dopamine depletion fMRI studyda Silva Alves, F. / Bakker, G. / Schmitz, N. / Abeling, N. / Hasler, G. / van der Meer, J. / Nederveen, A. / de Haan, L. / Linszen, D. / van Amelsvoort, T. et al. | 2013
- 1587
-
A proof of concept study of tolcapone for pathological gambling: Relationships with COMT genotype and brain activationGrant, J. E. / Odlaug, B. L. / Chamberlain, S. R. / Hampshire, A. / Schreiber, L. R. / Kim, S. W. et al. | 2013
- 1597
-
Limited utility of number needed to treat and the polarity index for bipolar disorder to characterize treatment responseAlphs, L. / Berwaerts, J. / Turkoz, I. et al. | 2013
- 1600
-
Association study between BDNF gene variants and Mexican patients with obsessive–compulsive disorderMárquez, L. / Camarena, B. / Hernández, S. / Lóyzaga, C. / Vargas, L. / Nicolini, H. et al. | 2013
- 1606
-
Effects of acute detoxification of the herbal blend ‘Spice Gold’ on dopamine D2/3 receptor availability: A [18F]fallypride PET studyRominger, A. / Cumming, P. / Xiong, G. / Koller, G. / Förster, S. / Zwergal, A. / Karamatskos, E. / Bartenstein, P. / La Fougère, C. / Pogarell, O. et al. | 2013
- 1611
-
Paraventricular nucleus of the hypothalamus glutamate neurotransmission modulates autonomic, neuroendocrine and behavioral responses to acute restraint stress in ratsBusnardo, C. / Alves, F. H. / Crestani, C. C. / Scopinho, A. r. / Resstel, L. B. / Correa, F. M. et al. | 2013
- 1623
-
Blockade of ventral midbrain NMDA receptors enhances brain stimulation reward: A preferential role for GluN2A subunitsBergeron, S. / Rompré, P. P. et al. | 2013
- 1636
-
Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatmentKarlsson, L. / Carlsson, B. r. / Hiemke, C. / Ahlner, J. / Bengtsson, F. / Schmitt, U. / Kugelberg, F. C. et al. | 2013
- 1645
-
Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatineMolteni, R. / Macchi, F. / Zecchillo, C. / Dell'Agli, M. / Colombo, E. / Calabrese, F. / Guidotti, G. / Racagni, G. / Riva, M. A. et al. | 2013
- 1656
-
Number needed to treat can be helpful: A response to Alphs et al.Citrome, L. / Ketter, T. A. et al. | 2013
- 1658
-
Response to Drs. Citrome and KetterAlphs, L. / Turkoz, I. / Berwaerts, J. et al. | 2013
- 1659
-
Autoimmune-induced glutamatergic receptor dysfunctions: Conceptual and psychiatric practice implicationsRosenthal-Simons, A. / Durrant, A. R. / Heresco-Levy, U. et al. | 2013
- 1672
-
The role of inflammatory cytokines in suicidal behavior: A systematic reviewSerafini, G. / Pompili, M. / Elena Seretti, M. / Stefani, H. / Palermo, M. / Coryell, W. / Girardi, P. et al. | 2013
- 1687
-
The endocannabinoid system and emotional processing: A pharmacological fMRI study with ∆9-tetrahydrocannabinolBossong, M. G. / van Hell, H. H. / Jager, G. / Kahn, R. S. / Ramsey, N. F. / Jansma, J. M. et al. | 2013
- 1698
-
Cocaine users with comorbid Cluster B personality disorders show dysfunctional brain activation and connectivity in the emotional regulation networks during negative emotion maintenance and reappraisalAlbein-Urios, N. / Verdejo-Román, J. / Soriano-Mas, C. / Asensio, S. / Martínez-González, J. M. / Verdejo-García, A. et al. | 2013
- 1708
-
Low single dose gabapentin does not affect prefrontal and occipital gamma-aminobutyric acid concentrationsPreuss, N. / van der Veen, J. W. / Carlson, P. J. / Shen, J. / Hasler, G. et al. | 2013
- 1714
-
Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependenceCrunelle, C. L. / van den Brink, W. / Veltman, D. J. / van Emmerik-van Oortmerssen, K. / Dom, G. / Schoevers, R. A. / Booij, J. et al. | 2013
- 1724
-
Oxytocin administration alters HPA reactivity in the context of parent–infant interactionWeisman, O. / Zagoory-Sharon, O. / Feldman, R. et al. | 2013
- 1732
-
Pharmacological treatment and demographic characteristics of pediatric patients with Attention Deficit Hyperactivity Disorder, SwedenBahmanyar, S. / Sundström, A. / Kaijser, M. / von Knorring, A. L. / Kieler, H. et al. | 2013
- 1739
-
Challenging sequential approach to treatment resistant depression: Cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR⁎D) trialOlgiati, P. / Bajo, E. / Bigelli, M. / Montgomery, S. / Serretti, A. et al. | 2013
- 1747
-
Topical ibuprofen inhibits blushing during embarrassment and facial flushing during aerobic exercise in people with a fear of blushingDrummond, P. D. / Minosora, K. / Little, G. / Keay, W. et al. | 2013
- 1754
-
Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS®) in the Swedish COAST-studyBrain, C. / Allerby, K. / Sameby, B. / Quinlan, P. / Joas, E. / Karilampi, U. / Lindström, E. / Eberhard, J. / Burns, T. / Waern, M. et al. | 2013
- 1763
-
Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly womenRyan, J. / Carrière, I. / Amieva, H. / Rouaud, O. / Berr, C. / Ritchie, K. / Scarabin, P. Y. / Ancelin, M. L. et al. | 2013
- 1769
-
Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: Involvement of nitric oxidePereira, V. S. / Casarotto, P. C. / Hiroaki-Sato, V. c. / Sartim, A. G. / Guimarães, F. S. / Joca, S. m. et al. | 2013
- 1779
-
β-endorphin degradation and the individual reactivity to traumatic stressKavushansky, A. / Kritman, M. / Maroun, M. / Klein, E. / Richter-Levin, G. / Hui, K. S. / Ben-Shachar, D. et al. | 2013
- 1789
-
Electroconvulsive stimulation reverses anhedonia and cognitive impairments in rats exposed to chronic mild stressHenningsen, K. / Woldbye, D. P. / Wiborg, O. et al. | 2013
- 1795
-
NMDA receptor antagonist-enhanced high frequency oscillations: Are they generated broadly or regionally specific?Olszewski, M. / Dolowa, W. / Matulewicz, P. / Kasicki, S. / Hunt, M. J. et al. | 2013
- 1806
-
Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: Molecular and behavioral aspectsLevi, I. / Eskira, Y. / Eisenstein, M. / Gilon, C. / Hoffman, A. / Talgan, Y. / Fanous, J. / Bersudsky, Y. / Belmaker, R. / Agam, G. et al. | 2013
- 1816
-
Juvenile ethanol exposure increases rewarding properties of cocaine and morphine in adult DBA/2J miceMolet, J. / Hervé, D. / Thiébot, M. H. / Hamon, M. / Lanfumey, L. et al. | 2013
- S1
-
S.01.01 Induced pluripotent stem cells and in vitro models of neurodevelopmental disordersPrice, J. et al. | 2013
- S2
-
S.01.02 Novel strategies for probing 3D structures of GPCRsMarshall, F. et al. | 2013
- S3
-
P.1.001 3-Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pore, not by activating mitochondrial fissionSolesio, M. E. / Saez-Atienzar, S. / Jordan, J. / Galindo, M. F. et al. | 2013
- S4
-
P.1.002 Pharmacological characterisation of positive allosteric modulators acting on the metabotropic glutamate receptor 2Bennett, K. A. / Weaver, A. / Marshall, F. / Langmead, C. J. et al. | 2013
- S5
-
P.1.003 Inflammatory response in the brain of rats exposed to chronic mild stressZecchillo, C. / Macchi, F. / Molteni, R. / Racagni, G. / Papp, M. / Riva, M. A. et al. | 2013
- S7
-
P.1.006 Oxytocin controls CRF gene expression through TORC3: implications for stress-related disordersJurek, B. / Slattery, D. A. / Liu, Y. / Neumann, I. D. / Aguilera, G. / van den Burg, E. H. et al. | 2013
- S8
-
P.1.007 A proteomic and functional analysis reveals that 5-HT6 receptors modulate neuronal differentiation by recruitment of Cdk5Duhr, F. / Seveno, M. / Mannoury la Cour, C. / Dupuis, D. / Millan, M. J. / Bockaert, J. / Marin, P. / Chaumont-Dubel, S. et al. | 2013
- S9
-
P.1.008 V1B/CRF1 receptor heterodimerisation as a key mechanism of vasopressin and corticotropin-releasing factor synergismMion, J. / Boulay, V. / Millan, M. J. / Guillon, G. / Corbani, M. et al. | 2013
- S10
-
P.1.009 Cell synchronisation as a tool to optimise expression of metabotropic glutamate receptors in inducible mammalian expression systemChruscicka, B. / Branski, P. / Burnat, G. / Pilc, A. et al. | 2013
- S11
-
P.1.010 The identification of protein tyrosine phosphatase, non-receptor type 1 in hippocampal modulation of food anticipatory behaviourKostrzewa, E. / Verhagen, L. A. / Gelegen, C. / van Lith, H. A. / Collier, D. A. / Mitsogiannis, M. / de Vries, E. / van Gestel, M. / Adan, R. A. / Kas, M. J. et al. | 2013
- S13
-
P.1.013 Chronic (-)cannabidiol produces antidepressant-like effects in bulbectomised mice, acting on 5-HT1A and CB1 receptor functionalityLinge, R. / Pazos, A. / Diaz, A. et al. | 2013
- S14
-
P.1.014 Intracerebroventricular administration of interleukin-1b elevates brain kynurenic acid and disrupts prepulse inhibition in C57BL/6 miceLarsson, M. / Schwieler, L. / Engberg, G. / Powell, S. B. / Erhardt, S. et al. | 2013
- S15
-
P.1.015 Time-dependent adaptations at the level of dopamine D2 receptor in stress-resilient ratsZurawek, D. / Faron-Gorecka, A. / Kusmider, M. / Kolasa, M. / Gruca, P. / Papp, M. / Dziedzicka-Wasylewska, M. et al. | 2013
- S16
-
P.1.017 Histaminergic regulation of presumed serotonin neurons in the dorsal raphe nucleusPanetta, K. / Belelli, D. / Lambert, J. et al. | 2013
- S17
-
P.1.018 Dissecting the neural mechanisms underlying impaired threat detection in the Ahi1 knockout mouseLotan, A. / Lifschytz, T. / Slonimsky, A. / Abedat, S. / Fellig, Y. / Cohen, H. / Lory, O. / Goelman, G. / Lerer, B. et al. | 2013
- S18
-
P.1.019 Role of the 5-HT2A receptor in the mechanism of action of antidepressant drugs: a translational human-mouse studyQuesseveur, G. / Petit, A. C. / Gressier, F. / Colle, R. / David, D. J. / Gardier, A. M. / Verstuyft, C. / Corruble, E. / Guiard, B. P. et al. | 2013
- S19
-
P.1.020 The role of CREB/BDNF/TrkB signalling in the zinc deficiency model of depressionDoboszewska, U. / Szewczyk, B. / Sowa-Kucma, M. / Mlyniec, K. / Nowak, G. et al. | 2013
- S20
-
P.1.021 Chronic administration of haloperidol in rats and its effect on microglial cell density and whole brain weight and volumeBloomfield, P. S. / Howes, O. D. / de Paola, V. et al. | 2013
- S21
-
P.1.022 Role of trace amine-associated receptor 1 (TAAR1) in the modulation of the dopaminergic system and cortico-striatal signallingEspinoza, S. / Sukhanov, I. / Lignani, G. / Medrihan, L. / Maggi, S. / Giannotti, G. / Fumagalli, F. / Benfenati, F. / Tucci, V. / Gainetdinov, R. et al. | 2013
- S22
-
P.1.024 Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addictionSagheddu, C. / Melis, M. / Pistis, M. et al. | 2013
- S25
-
S.02.02 Developmental models of schizophrenia and their behavioural characterisationFone, K. C. / Watson, D. J. / McIntosh, A. / King, M. V. et al. | 2013
- S27
-
P.2.002 Behavioural, molecular and glutamatergic changes in a developmental model of schizophrenia, and reversal by a 5-HT6 receptor antagonistKing, M. V. / Negm, O. / Tighe, P. / Knapp, S. / Wigmore, P. / Fone, K. C. et al. | 2013
- S28
-
P.2.003 Sub-anaesthetic ketamine modulates intrinsic blood oxygen level-dependent (BOLD) connectivity between the hippocampus and the prefrontal cortex in the ratGass, N. / Sartorius, A. / Schwarz, A. J. / Schenker, E. / Risterucci, C. / Spedding, M. / Zheng, L. / Meyer-Lindenberg, A. / Weber-Fahr, W. et al. | 2013
- S29
-
P.2.004 The dopamine b-hydroxylase inhibitor nepicastat suppresses different chocolate-motivated behaviours in ratsZaru, A. et al. | 2013
- S30
-
P.2.005 The trans-isomer of resveratrol acutely improves motivation in ratSamardzic, J. / Gojkovic-Bukarica, L. / Obradovic, D. I. et al. | 2013
- S31
-
P.2.006 Effects of serotonin (5-HT)1B receptor ligands on amphetamine-seeking behaviour in ratsMiszkiel, J. / Przegalinski, E. et al. | 2013
- S33
-
P.2.009 Effect of early life experiences on brain structure and function: neurogenesis and decision makingLoi, M. / Koricka, S. / de Visser, L. / Kas, M. J. / Lucassen, P. J. / Joels, M. et al. | 2013
- S34
-
P.2.010 Effects of L-DOPA and sarizotan treatments in a parkinsonian rat model of depressionSchintu, N. / Zhang, X. / Mathe, A. A. / Svenningsson, P. et al. | 2013
- S35
-
P.2.011 GluA1 and its Postsynaptic density protein 95 (PSD-95)/Discs large/Zonula occludens-1 (PDZ)-interaction: a role in experience-dependent behavioural plasticity in the forced swim testFreudenberg, F. / Marx, V. / Mack, V. / Layer, L. E. / Klugmann, M. / Seeburg, P. H. / Sprengel, R. / Celikel, T. et al. | 2013
- S37
-
P.2.014 Serotonin receptor 2B knockout mice present schizophrenic-like behaviourPitychoutis, P. M. / Maroteaux, L. et al. | 2013
- S38
-
P.2.015 Low performing rats model the inattentive subtype of adult ADHD in the 5-choice continuous performance task (5C-CPT)Tomlinson, A. / Marshall, K. M. / Neill, J. C. et al. | 2013
- S39
-
P.2.016 Exposure to an alternative reward does not reduce cocaine-seeking behaviourNicolas, C. / Lafay-Chabassier, C. / Solinas, M. et al. | 2013
- S40
-
P.2.017 The hallucinogen 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) disrupts cortical function: reversal by antipsychotic drugsRiga, M. S. / Artigas, F. / Celada, P. et al. | 2013
- S42
-
P.2.020 Disruption of 5-HT7 receptors accelerates age-related episodic-like memory declineBeaudet, G. / Brehin, M. / Freret, T. / Nee, G. / Delaunay, V. / Boulouard, M. / Paizanis, E. et al. | 2013
- S43
-
P.2.021 Role of adenosine (A)2A receptor in nicotine addiction - pharmacological and genetic aspectsCzyzyk, J. / Nowak, E. / Bader, M. / Fuxe, K. / Filip, M. et al. | 2013
- S44
-
P.2.022 Oxytocin in the central nucleus of the amygdala mediates social buffering of fearRickenbacher, E. / Moita, M. et al. | 2013
- S46
-
P.2.025 Ventral medial prefrontal cortex inactivation reduces context-induced reinstatement of nicotine seekingStruik, R. F. / Peters, J. / Jonkman-Tielemans, S. / De Vries, T. J. et al. | 2013
- S47
-
P.2.026 Pro-inflammatory cytokines induce anhedonia in mice and increase monoamine transporter activity in the nucleus accumbensvan Heesch, F. / Prins, J. / Westphal, K. G. / Korte-Bouws, G. A. / Olivier, B. / Kraneveld, A. D. / Korte, S. M. et al. | 2013
- S48
-
P.2.027 a7 nicotinic acetylcholine receptor (a7 nAChR) agonists or antagonists as potential cognition enhancers?Van Goethem, N. P. / Prickaerts, J. et al. | 2013
- S49
-
P.2.028 Enhanced vulnerability to cocaine reinforcing effects in female H/Rouen mice selectively bred for depressive-like behaviourRappeneau, V. / Morel, A. L. / Luppi, P. H. / Vaugeois, J. M. / El Yacoubi, M. / Berod, A. et al. | 2013
- S50
-
P.2.030 Are nutritional variables associated with cognition in stimulant-dependence?Whitelock, C. F. / Ersche, K. D. et al. | 2013
- S51
-
P.2.031 The CBA/J mouse as a genetic model of visceral hypersensitivity with co-morbid anxiety and depression: role of glutamate transportMoloney, R. D. / Dinan, T. G. / Cryan, J. F. et al. | 2013
- S52
-
P.2.032 Nanoparticles as disease-modifying mediators for brain therapy: focus on Huntingtons diseaseGodinho, B. M. / Ogier, J. R. / Darcy, R. / ODriscoll, C. M. / Cryan, J. F. et al. | 2013
- S54
-
P.2.035 `Anxious' rats exhibit an enhanced anxiogenic response to acute SSRI treatment and indices of heightened serotonergic transmissionNaslund, J. / Studer, E. / Petterson, R. / Nissbrandt, H. / Eriksson, E. et al. | 2013
- S57
-
P.3.001 Valproic acid treatment prevents the development of deficit in sensorimotor gating in adult prenatally methylazoxymethanol-treated ratsLatusz, J. / Bator, E. / Mordalska, P. / Wedzony, K. / Mackowiak, M. et al. | 2013
- S58
-
P.3.002 The effect of valproic acid on changes in methylation pattern of histone H3 induced by prenatal MAM administration in mPFCBator, E. / Latusz, J. / Mordalska, P. / Wedzony, K. / Mackowiak, M. et al. | 2013
- S59
-
P.3.003 Chronic early-life stress programs hippocampal neurogenesis and cognitive function: a role for epigenetics?Naninck, E. F. / Hoeijmakers, L. / Engel, M. / Lucassen, P. J. / Korosi, A. et al. | 2013
- S61
-
P.3.006 Epigenetic modifications of bdnf gene at hippocampal level induced by chronic ethanol intake in C57BL/6J miceStragier, E. / Massart, R. / Hamon, M. / Lanfumey, L. et al. | 2013
- S62
-
P.3.007 Stress-induced miRNA changes in depression: peripheral biomarker or pathophysiology?Kalman, S. / Garbett, K. / Vereczkei, A. / Shelton, R. C. / Mirnics, K. et al. | 2013
- S63
-
P.3.008 S-Adenosyl-methionine impairs forced swimming-induced behavioural immobility by inhibiting gene expression in dentate gyrus neuronsSaunderson, E. A. / Trollope, A. F. / Gutierrez-Mecinas, M. / Shaikh, A. A. / Spiers, H. / Mill, J. / Reul, J. M. et al. | 2013
- S64
-
P.3.009 Differential effects of prenatal stress on serotonin transporter deficient mice: the role of epigenetic programmingSchraut, K. / Jakob, S. B. / Kenis, G. / Schmitt, A. G. / Kneitz, S. / Scholz, C. J. / Ortega, G. / Steinbusch, H. / van den Hove, D. L. / Lesch, K. P. et al. | 2013
- S67
-
S.04.01 Disrupted cerebral connectivity and brain disorders: linking circuits to genesMeyer-Lindenberg, A. / Tost, H. / Bilek, E. et al. | 2013
- S68
-
P.4.001 Clinical implications of polarity index of drugs in maintenance treatment of bipolar disorder: a naturalistic studyPopovic, D. / Vieta, E. et al. | 2013
- S69
-
P.4.002 Genetic differences in drug-metabolising enzymes: can they be used to predict antidepressant treatment response?Hodgson, K. / Tansey, K. E. / Uher, R. / Daivs, O. S. / Aitchison, K. J. / McGuffin, P. et al. | 2013
- S71
-
P.4.005 Effects of cigarette smoking on schizophrenia treatment with olanzapineZoric, K. / Zivkovic, N. / Djokic, G. et al. | 2013
- S72
-
P.4.006 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging studyde Leeuw, M. / Vink, M. / Kahn, R. S. et al. | 2013
- S73
-
P.4.007 Associations of antiepileptic drugs with anxiety and depressive symptoms in paediatric epilepsy: a pilot studyStevanovic, D. / Jancic, J. et al. | 2013
- S74
-
P.4.009 Age at onset and cognitive impairment in schizophrenia: an ecological cross-sectional study with stabilised patientsCaldiroli, A. / Buoli, M. / Caletti, E. / Paoli, R. A. / Zago, S. / Altamura, A. C. et al. | 2013
- S75
-
P.4.010 Association of personality features with lithium prophylactic responseDembinska-Krajewska, D. / Kliwicki, S. / Chlopocka-Wozniak, M. / Rybakowski, J. et al. | 2013
- S76
-
P.4.011 Clinical features and drug-induced side effects in early versus late antidepressant respondersFabbri, C. / Marsano, A. / Balestri, M. / Serretti, A. et al. | 2013
- S77
-
P.4.012 Effects of second generation antipsychotics on cognitive domains measured with the Matrics Consensus Cognitive Battery in early psychosesMontalvo, I. / Creus, M. / Gutierrez-Zotes, A. / Ortega, L. / Monseny, R. / Feliu, T. / Franch, J. / Vilella, E. / Labad, J. et al. | 2013
- S78
-
P.4.013 Modulation of brain structure by catechol O-methyltransferase ValMet polymorphism in chronic cannabis usersBatalla, A. / Soriano-Mas, C. / Torrens, M. / Crippa, J. A. / Bhattacharyya, S. / Blanco-Hinojo, L. / Harrison, B. J. / Farre, M. / Pujol, J. / Martin-Santos, R. et al. | 2013
- S80
-
P.4.016 Regional differences of SERT occupancy in major depression: an in vivo PET study using [C]DASBBaldinger, P. / Kranz, G. S. / Savli, M. / Wadsak, W. / Haeusler, D. / Hahn, A. / Mitterhauser, M. / Philippe, C. / Kasper, S. / Lanzenberger, R. et al. | 2013
- S81
-
P.4.017 Post training noradrenaline reuptake inhibition modulates fear memory consolidation and abolishes long term fear responses in humansAlmeida, J. / Tulen, J. / van der Veen, F. / Kushner, S. et al. | 2013
- S82
-
P.4.018 General error monitoring system dysfunction in obsessive compulsive disorder patients: an event-related potential studyCarmi, L. / Alyagon, U. / Zangen, A. / Dar, R. / Zohar, J. et al. | 2013
- S83
-
P.4.019 Insight and recovery in schizophrenic patients: an observational studyCannavo, D. / Concerto, C. / Battaglia, E. / Bianchini, O. / Aguglia, E. et al. | 2013
- S84
-
P.4.020 Allopurinol for mania - a randomised trial of allopurinol vs. placebo as add-on treatment in manic bipolar patientsBurshtein, S. / Weiser, M. / Gershon, A. A. / Marian, G. / Vlad, N. / Grecu, I. G. / Tocari, E. / Tiugan, A. / Hotineanu, M. / Davis, J. M. et al. | 2013
- S86
-
P.4.023 Habenular nuclei in different phases of major depressive disorder: a magnetic resonance imaging volumetric studyDe Diego-Adelino, J. / Carceller, M. / Serra-Blasco, M. / Vives-Gilabert, Y. / Gomez-Anson, B. / Puigdemont, D. / Alvarez, E. / Perez, V. / Portella, M. J. et al. | 2013
- S87
-
P.4.024 Using positron emission tomography to investigate microglial activation in alcohol dependence: preliminary findingsKalk, N. J. / Guo, Q. / Cherian, R. / Erritzoe, D. / Waldman, A. / Dar, K. / Gunn, R. N. / Nutt, D. J. / Rabiner, E. A. / Lingford-Hughes, A. R. et al. | 2013
- S88
-
P.4.025 Effects of deep brain stimulation of prelimbic and infralimbic areas of the prefrontal cortex of the ratJimenez-Sanchez, L. / Perez-Caballero, L. / Castane, A. / Lopez-Gil, X. / Campa, L. / Galofre, M. / Berrocoso, E. / Adell, A. et al. | 2013
- S89
-
P.4.027 Six-month follow-up study of repetitive transcranial magnetic stimulation in the treatment of resistant major depressive disorderConcerto, C. / Cannavo, D. / Magnano SanLio, F. / Ricceri, R. / Lanza, G. / Aguglia, E. et al. | 2013
- S92
-
P.4.031 Effects of mental distress on cognitive functioning in patients admitted for cardiac rehabilitation after acute coronary eventsBurkauskas, J. / Brozaitiene, J. / Bunevicius, R. et al. | 2013
- S93
-
P.4.032 Neuroinflammation in temporal cortex in schizophrenia patientsvan der Doef, T. F. / Yaqub, M. / Bossong, M. G. / Boellaard, R. / Windhorst, A. D. / Lammertsma, A. A. / Kahn, R. S. / van Berckel, B. N. et al. | 2013
- S94
-
P.4.033 Cerebrospinal fluid biomarkers of brain injury in bipolar disorderJakobsson, J. / Palsson, E. / Ekman, C. J. / Sellgren, C. / Johansson, A. G. / Zetterberg, H. / Blennow, K. / Landen, M. et al. | 2013
- S95
-
P.4.034 Glucose abnormalities in newly diagnosed, medication-naive patients with bipolar disorder, mania, and psychosisGarcia-Rizo, C. / Kirkpatrick, B. / Fernandez-Egea, E. / Oliveira, C. / Grande, I. / Undurraga, J. / Vieta, E. / Bernardo, M. et al. | 2013
- S96
-
P.4.035 Clinical improvement and plasmatic concentrations of fluoxetine in major depressive disorder (MDD), obsessive-compulsive disorder (OCD) and generalised anxiety disorder (GAD)Blazquez, A. / Mas, S. / Plana, M. T. / Lafuente, A. / Mendez, I. / Lazaro, L. et al. | 2013
- S97
-
P.4.036 Corticotropin-releasing hormone and serotonin - the neuropsychopharmacology of fear learning deficit from rodents to humansHeitland, I. / Groenink, L. / Bijlsma, E. Y. / Oosting, R. S. / Kenemans, J. L. / Baas, J. M. et al. | 2013
- S98
-
P.4.038 Effect of neuregulin-1 gene functional variant and environmental factors on alcohol use disorderVaht, M. / Kiive, E. / Laas, K. / Parik, J. / Veidebaum, T. / Harro, J. et al. | 2013
- S101
-
Author Index| 2013
- S105
-
Keyword Index| 2013
- S107
-
PL.03.01 Understanding pain in somatoform disordersSommer, C. et al. | 2013
- S108
-
PL.05.01 The future of molecular pharmacology and drug discovery in psychiatryCaron, M. / Urs, N. M. / Peterson, S. M. / Snyder, J. C. et al. | 2013
- S111
-
S.01.03 Autism: from static genetic brain defect to dynamic gene-environment modulated pathophysiologyHerbert, M. R. et al. | 2013
- S113
-
S.02.04 Insular dysfunction and descending pain inhibition in anorexia nervosaBär, K. J. / Beissner, F. / Wagner, G. et al. | 2013
- S114
-
S.03.03 Dynamics of structural connections in schizophreniaPol, H. E. et al. | 2013
- S115
-
S.04.02 Tau, axonal transport and Alzheimers diseaseMandelkow, E. M. / Sydow, A. / Hochgräfe, K. / Kumar, Y. / Zempel, H. / Mandelkow, E. et al. | 2013
- S116
-
S.05.01 Lithium: still a cornerstone in the long-term treatment of bipolar disorder?Nolen, W. et al. | 2013
- S117
-
S.05.03 Atypical antipsychotics in bipolar disorder and schizophrenia: similarities and discrepanciesLeucht, S. et al. | 2013
- S118
-
S.06.02 Quantitative electroencephalographic assessment of ADHDSimon, V. et al. | 2013
- S120
-
S.07.03 Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addictionSagheddu, C. / Melis, M. / De Felice, M. / Colombo, G. / Pistis, M. et al. | 2013
- S121
-
S.07.06 Epigenetic modifications of the BDNF gene at hippocampal level induced by chronic ethanol intake in C57BL/6J miceStragier, E. / Massart, R. / Hamon, M. / Lanfumey, L. et al. | 2013
- S123
-
S.08.03 Modelling extracellular neurotransmitter dynamics following chronic drug administrationNoori, H. R. et al. | 2013
- S124
-
S.09.02 Altering the cortico striatal circuitry in impulsivity and compulsivity: new neuro-imaging findingsVulink, N. C. / Denys, D. et al. | 2013
- S125
-
S.09.04 Emotional regulation and impulsivity in borderline personality disorder: experimental and fMRI findingsJacob, G. / Tüscher, O. et al. | 2013
- S126
-
S.10.04 Extrapyramidal and metabolic side effects of antipsychotic treatment: data from EUFESTRybakowski, J. K. et al. | 2013
- S127
-
S.11.02 Epigenetic control of stress-induced gene transcription and behaviour: relevance to PTSDReul, J. M. et al. | 2013
- S128
-
S.12.01 Identification of a significant role for the ventral hippocampus in neuropeptide S-elicited anxiolysisIonescu, I. A. / Dine, J. / Stepan, J. / Yen, Y. C. / Herrmann, L. / Holsboer, F. / Wotjak, C. T. / Landgraf, R. / Eder, M. / Schmidt, U. et al. | 2013
- S129
-
S.12.04 Targeting postsynaptic density protein 95(PSD-95)/Discs large/Zonula occludens-1 (PDZ)-interactions of the glutamatergic synapse in animal models of depressionFreudenberg, F. / Marx, V. / Mack, V. / Layer, L. E. / Klugmann, M. / Seeburg, P. H. / Sprengel, R. / Celikel, T. et al. | 2013
- S131
-
S.13.011 Adherence to a single disease paradigm is not the way to move forward in the treatment of schizophreniaArango, C. et al. | 2013
- S132
-
S.13.03 Guiding the development of new treatments for refractory schizophrenia – insights from PET and MRS studies of patientsHowes, O. et al. | 2013
- S133
-
S.14.01 Can brain connectivity predict outcome in alcoholism treatment: the TRANSALC projectSommer, W. H. / Weber-Fahr, W. / Vollstädt-Klein, S. / Meinhardt, M. W. / Brown, M. / Hyytä, P. / Canals, S. / Mann, K. / Hermann, D. et al. | 2013
- S134
-
S.14.04 Testing the effect of modafinil on functional connectivity and impulsivity in alcohol dependent patientsSchmaal, L. / Goudriaan, A. E. / Joos, L. / Dom, G. / Van den Brink, W. / Veltman, D. J. et al. | 2013
- S136
-
S.16.04 A non convulsant alpha5 selective GABA-A inverse agonist restores cognitive deficits in a mouse model of Down syndromeDelatour, B. / Braudeau, J. / Duchon, A. / Dauphinot, L. / Dodd, R. H. / Hérault, Y. / Potier, M. C. et al. | 2013
- S137
-
S.17.03 The nucleus accumbens: a safe and well tolerated target for DBS in treatment resistant depressionMillet, B. / Le Jeune, F. / Jaafari, N. / Polosan, M. / Giordana, B. / Naudet, F. / Reymann, J. M. / Fossati, P. / Cornu, P. et al. | 2013
- S141
-
S.20.01 The stress impact on glutamate transmission: a key to mood and anxiety disordersPopoli, M. / Musazzi, L. / Treccani, G. et al. | 2013
- S142
-
S.20.04 Application of mGlu5 receptor antagonists in L-DOPA induced dyskinesia and in fragile X syndromeGasparini, F. et al. | 2013
- S143
-
S.22.03 Neuroimaging of fear conditioning and reward/punishment anticipation in the persistence of antisocial behaviourCohn, M. D. / Popma, A. / Van den Brink, W. / Pape, L. E. / Kindt, M. / Van Domburgh, L. / Doreleijers, T. A. / Veltman, D. J. et al. | 2013
- S144
-
S.23.02 Imaging of the opioid and dopamine systemRosen, B. et al. | 2013
- S146
-
S.24.03 Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptorsSalter, M. W. et al. | 2013
- S148
-
S.25.04 Genetics of suicidal behaviour in bipolar disorder: an updateBenabarre, A. et al. | 2013
- S150
-
S.27.01 Mitochondria and Aβ metabolismAnkarcrona, M. et al. | 2013
- S151
-
S.27.04 Therapeutic intervention at the mitochondrial levelMüller, W. et al. | 2013
- S152
-
S.28.02 GABAergic interneurons and their role in neuronal synchronisation – implications for schizophreniaMonyer, H. et al. | 2013
- S153
-
S.28.04 New pharmacological treatment strategies targeting GABAergic dysfunction in schizophreniaVinkers, C. H. et al. | 2013
- S155
-
E.03.01 Obesity: a treatable brain disease?Gearhardt, A. et al. | 2013
- S156
-
E.05.03 EPA Guidance and the future of European psychiatryGaebel, W. et al. | 2013
- S157
-
E.07.02 Clinical use of psychotropic drugs in youth – interests and pitfallsArango, C. et al. | 2013
- S159
-
P.1.a.002 Associations between ARLTL markers and symptoms dimensions in bipolar affective disorderMaciukiewicz, M. / Dmitrzak-Weglarz, M. / Czerski, P. M. / Leszczynska-Rodziewicz, A. / Kapelski, P. / Szczepankiewicz, A. / Skibinska, M. / Pawlak, J. / Hauser, J. / Karlowski, W. M. et al. | 2013
- S160
-
P.1.a.003 TNF-alpha −308 G>A polymorphism is associated with suicide attempt in major depressive disorderKim, Y. K. / Hong, J. P. / Na, K. S. / Han, S. W. / Lee, B. H. / Jung, H. Y. et al. | 2013
- S161
-
P.1.a.005 Association study of corticotropin-releasing hormone receptor 1 (CRHR1) gene polymorphism in Korean alcohol-dependent patientsKim, S. G. / Kim, C. M. / Kim, H. C. / Kim, H. K. / Kim, J. G. et al. | 2013
- S163
-
P.1.a.008 Increased DNA methylation of the prodynorphin gene promoter in peripheral blood mononuclear cells from patients with bipolar disorderDi Francesco, A. / DellOsso, B. / Palazzo, M. C. / Benatti, B. / Galimberti, D. / Arosio, B. / Altamura, A. C. / Maccarrone, M. / DAddario, C. et al. | 2013
- S164
-
P.1.a.009 The SNP rs2883187 of brain-derived neurotrophic factor (BDNF) is associated with symptom severity in obsessive-compulsive disorderTukel, R. / Ozata, B. / Ozturk, N. / Ertekin, B. A. / Ertekin, E. / Direskeneli, G. S. et al. | 2013
- S165
-
P.1.a.011 Lipopolysaccharide (LPS) induced histone modification in the rat brain: implications for psychiatric diseaseRigillo, G. et al. | 2013
- S166
-
P.1.a.013 5-HTT is associated with the endophenotype psychological flexibility: preliminary results from a randomised clinical trialGloster, A. / Wittchen, H. U. / Deckert, J. / Reif, A. et al. | 2013
- S167
-
P.1.a.015 No interaction of the 5-HTTLPR genetic polymorphism on body image dissatisfaction by neuroticism in a young adult Korean populationChee, I. S. / Wang, S. K. / Kim, J. L. / Lee, Y. H. et al. | 2013
- S168
-
P.1.a.016 CHL1 gene: a new promising antidepressant response marker in major depressionFabbri, C. / Gurwitz, D. / Stingl, J. / Crisafulli, C. / Spina, E. / Kasper, S. / Zohar, J. / Souery, D. / Mendlewicz, J. / Serretti, A. et al. | 2013
- S170
-
P.1.a.019 Association of glucocorticoid receptor gene NR3C1 polymorphisms and schizophrenia in a Korean populationKim, Y. / Kang, W. S. / Kim, J. W. / Cho, A. R. et al. | 2013
- S171
-
P.1.a.021 A molecular pathway analysis of the genes in 22q11.2 provides information on the genetic structure of psychosisDrago, A. / Crisafulli, C. / De Ronchi, D. / Serretti, A. et al. | 2013
- S172
-
P.1.a.023 NRG1 and DISCI gene polymorphisms with respect to cognitive endophenotype in schizophreniaFrydecka, D. / Kiejna, A. / Szewczuk-Boguslawska, M. / Beszlej, A. / Pawlak-Adamska, E. / Karabon, L. / Partyka, A. / Tomkiewicz, A. et al. | 2013
- S173
-
P.1.a.025 Age at onset of depressive disorder is associated with interaction of BDNF rs6265 and 5-HTTLPR polymorphismLee, K. / Joo, E. J. / Kim, E. J. et al. | 2013
- S174
-
P.1.b.001 Neural correlates of stressful life events at onset of obsessive-compulsive disorderReal, E. / Orfila, C. / Alonso, P. / Segalàs, C. / Labad, J. / Subirà, M. / Pinillos, M. / Cardoner, N. / Menchón, J. M. / Soriano-Mas, C. et al. | 2013
- S175
-
P.1.b.002 Event-related potentials in first-episode schizophrenia patients: relationship with clinical data and psychopharmacotherapyLykholetova, O. / Abramov, V. / Ivnev, B. / Snegir, A. et al. | 2013
- S176
-
P.1.b.004 Functional characterisation of human induced pluripotent stem cell-derived neurons in Gauchers diseaseGaval-Cruz, M. / Awad, O. / ODonnell, P. / Feldman, R. et al. | 2013
- S177
-
P.1.b.006 Auditory P300 in euthymic patients with bipolar disorderCustal, N. / Cerrillo, E. / Veciana, M. / Pedro, J. / Montero, J. / Crespo, J. M. / Menchón, J. M. et al. | 2013
- S179
-
P.1.b.009 Switching in bipolar disorder: the role of 3H-imipramine, 3H-paroxetine and 5-HT2 binding sitesCerrillo, E. / Custal, N. / Morchón, S. / Rosel, P. / Urretavizcaya, M. / Menchón, J. M. / Crespo, J. M. et al. | 2013
- S180
-
P.1.c.001 Cognitive impairment in children – candidate endophenotypes for schizophreniaSacuiu, I. / Burlea-Ciubara, A. / Chirita, V. / Chirita, R. et al. | 2013
- S181
-
P.1.C.002 Clinical and therapeutic correlates of neurological soft signs in first-episode psychosisMhalla, A. / Gassab, L. / Mechri, A. / Gaha, L. et al. | 2013
- S182
-
P.1.e.002 Sex-dependent effects of chronic L-thyroxine treatment in the water mazeTan, B. / Bitiktas, S. / Kavraal, S. / Kandemir, B. / Kurnaz, I. A. / Suer, C. et al. | 2013
- S183
-
P.1.e.004 Sex-hormone fluctuation triggers subclinical depressive symptoms and affects immune cell numbers in peripheral blood in healthy womenHeede, M. / Søndergaard, H. / Pinborg, A. / Christensen, K. / Ullum, H. / Sellebjerg, F. / Knudsen, G. / Frokjaer, V. et al. | 2013
- S184
-
P.1.e.005 Alterations of cortisol awakening response and DHEA in postpartum depressionSuh, H. S. / Ahn, R. S. / Kim, C. H. / Kim, Y. K. et al. | 2013
- S185
-
P.1.f.002 Suicide attempts and oxidative stress: is there a link?Martin Subero, M. / Odebrecht Vargas, H. / Nunes, S. O. / Barbosa, D. S. / Vargas, M. M. / Venugopal, K. / Berk, M. / Maes, M. et al. | 2013
- S186
-
P.1.f.004 Mirtazapine-induced serious acute thrombocytopeniaStuhec, M. et al. | 2013
- S187
-
P.1.f.005 Immune response correlates with behavioral activity, associated with memory processes following chronic stimulation of the medial septumPodlacha, M. / Myslinska, D. / Wrona, D. et al. | 2013
- S188
-
P.1.f.007 Effects of the administration of lipopolysaccharide and a murine T-lymphoma cell line on brain activation and immune function in male Wistar ratsPlucinska, K. / Cecot, T. / Majkutewicz, I. / Ciepielewski, Z. / Ptaszek, K. / Myslinska, D. et al. | 2013
- S190
-
P.1.g.004 Influence of ABCB-1 genotype on spontaneous sleep and sleep-EEG changes after escitalopram in healthy volunteersSteiger, A. / Kluge, M. / Dresler, M. / Wollweber, B. / Yassouridis, A. / Uhr, M. et al. | 2013
- S191
-
P.1.g.006 Neuroprotective and neurogenic effects of haloperidol and risperidone in the ischemic hippocampusKim, D. H. / Moon, Y. S. / Son, B. K. et al. | 2013
- S192
-
P.1.g.008 Sub-anesthetic ketamine modulates intrinsic BOLD connectivity between the hippocampus and the prefrontal cortex in the ratGass, N. / Schwarz, A. J. / Sartorius, A. / Schenker, E. / Risterucci, C. / Spedding, M. / Zheng, L. / Meyer-Lindenberg, A. / Weber-Fahr, W. et al. | 2013
- S193
-
P.1.g.009 Serotonin transporter binding is increased by a gonadotropin-releasing hormone agonist in female ratsOvergaard, A. / Lie, M. E. / Jorgensen, C. V. / Mikkelsen, J. D. / Knudsen, G. M. / Frokjaer, V. G. et al. | 2013
- S194
-
P.1.g.011 Effect of chronic fluoxetine treatment on subthalamic nucleus and catalepsy in the ratUgedo, L. / Morera-Herreras, T. / Ruiz-Ortega, J. A. / Vidaurrazaga, I. / Miguelez, C. / Aristieta, A. et al. | 2013
- S195
-
P.1.g.013 Effects of vortioxetine versus paroxetine on polysomnography in man: a pharmacokinetic/pharmacodynamic studyWilson, S. / Buchbjerg, J. / Højer, A. M. / Areberg, J. / Nutt, D. J. et al. | 2013
- S196
-
P.1.g.014 Vortioxetine, a novel multimodal antidepressant, modulates GABA and glutamate neurotransmission via serotonergic mechanismsPehrson, A. / Li, Y. / Haddjeri, N. / Gulinello, M. / Sanchez, C. et al. | 2013
- S197
-
P.1.g.016 Effects of tianeptine on mammalian target of rapamycin (mTOR) signaling in rat hippocampal neuronsSeo, M. K. / Lee, C. H. / Cho, H. Y. / Park, S. W. / Lee, B. J. / Lee, J. G. / Kim, Y. H. et al. | 2013
- S198
-
P.1.g.018 Serotonin receptor of type 6 (5-HT6) in human brain post-mortem. A pharmacology, immunohistochemistry and immunofluorescence studyBaroni, S. / Giannaccini, G. / DellOsso, L. / Marazziti, D. et al. | 2013
- S199
-
P.1.g.019 Comparison of the effect of norquetiapine, reboxetine and citalopram on monoamine levels in rat locus coeruleus and prefrontal cortexOrtega, J. E. / Horrillo, I. / Prieto, E. / Me ana, J. J. et al. | 2013
- S200
-
P.1.g.021 Dissociation of mGlu2/3 agonist effects on global and task related ketamine oxygen signals: the quest for translational biomarkersGastambide, F. / Francois, J. / Tricklebank, M. / Gilmour, G. et al. | 2013
- S202
-
P.1.g.024 Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophreniaMaat, A. / Cahn, W. / Gijsman, H. J. / Hovens, J. E. / Kahn, R. S. / Aleman, A. et al. | 2013
- S203
-
P.1.g.026 Neuroprotective tetrahydroisoquinoline alkaloids have antidepressant-like effects in the clonidine model of depressionAntkiewicz-Michaluk, L. / Romanska Irena, I. / Wasik, A. / Mozdzen, E. / Michaluk, J. et al. | 2013
- S204
-
P.1.g.027 Antidepressant-like effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline in a reserpine model of depression in ratMichaluk, J. / Mozdzen, E. / Wasik, A. / Romanska, I. / Antkiewicz-Michaluk, L. et al. | 2013
- S205
-
P.1.g.029 Opioid and GABAergic pathways interactions modulate panic-like behaviours organised by the superior colliculusDa Silva, J. A. / Coimbra, N. C. et al. | 2013
- S206
-
P.1.g.031 Functional coupling of group II metabotropic glutamate receptors to Gα-proteins in postmortem frontal cortex of schizophrenic subjectsGarcía-Bea, A. / Miranda-Azpiazu, P. / Díez-Alarcia, R. / Gabilondo, A. M. / Morentín, B. / González-Maeso, J. / Meana, J. J. et al. | 2013
- S207
-
P.1.g.033 Effects of anandamide on panic-like elaborated escape behavior evoked by GABAA receptor blockade in the ventromedial hypothalamusGarcia, T. A. / De Freitas, R. L. / Coimbra, N. C. et al. | 2013
- S208
-
P.1.g.034 Effect of lisdexamfetamine in a rat model of binge-eating disorderHeal, D. / Vickers, S. / Hackett, D. / Hutson, P. et al. | 2013
- S209
-
P.1.g.036 Role of cannabinoid CB1 receptor in the regulation of aggressive social behaviourRodríguez-Arias, M. / Rueda, F. N. / Daza-Losada, M. / Navarro, D. / Aguilar, M. A. / Berbel, P. / Miñarro, J. / Manzanares, J. et al. | 2013
- S211
-
P.1.g.039 Behavioural and neurochemical evidence for implication of the cannabinoid CB1 receptor in the effects of d-amphetaminePolissidis, A. / Galanopoulos, A. / Chouliara, O. / Papadopoulou-Daifoti, Z. / Antoniou, K. et al. | 2013
- S213
-
P.1.g.042 A study on the effects of psychotropic drug use during pregnancy on fetal development in female patients with psychiatric disordersChung, Y. / Lee, E. / Noh, J. et al. | 2013
- S214
-
P.1.g.044 Effects of pharmacologically induced sex-hormone fluctuations on emotional processing of faces in healthy womenHenningsson, S. / Madsen, K. H. / Pinborg, A. / Heede, M. / Knudsen, G. M. / Siebner, H. R. / Frokjaer, V. G. et al. | 2013
- S216
-
P.1.g.047 The effect of cannabis on memory function in users with and without a psychotic disorder: a meta-analysisSchoeler, T. / Kambeitz, J. / Bhattacharyya, S. et al. | 2013
- S217
-
P.1.g.049 Does the peroxisome proliferator-activated receptor (PPAR)-alpha agonist fenofibrate protect against dopaminergic neuronal death in a rat model of Parkinsons disease?Barbiero, J. K. / Santiago, R. M. / Tonin, F. S. / Boschen, S. / Motta, L. / Werner, M. F. / Da Cunha, C. / Lima, M. M. / Vital, M. et al. | 2013
- S219
-
P.1.g.052 Understanding blood-brain barrier penetration and link to target engagementSinha, V. / Loryan, I. / De Boer, P. / Langlois, X. / Mackie, C. / Van Peer, A. / Drinkenburg, W. / Vermeulen, A. / Heald, D. / Hammarlund-Udenaes, M. et al. | 2013
- S220
-
P.1.g.054 Gene-expression imaging by N-methyl-D-aspartate receptor antagonists: implications for dopamine–glutamate interplay in psychosisBuonaguro, E. F. / Marmo, F. / Sarappa, C. / Eramo, A. / Tomasetti, C. / Iasevoli, F. / De Bartolomeis, A. et al. | 2013
- S221
-
P.1.g.055 5-HT2A/2C serotonergic receptors of lateral septal area modulate fear-induced responses elicited by activation of dorsolateral periaqueductal grey matterDe Oliveira, R. / De Oliveira, R. C. / Coimbra, N. C. et al. | 2013
- S222
-
P.1.g.057 Relationship between plasma and tissue ghrelin levels and antimuscarinic induced convulsions in fasted mice after food intakeTurkmen, A. Z. / Nurten, A. et al. | 2013
- S223
-
P.1.g.059 Effects of antiepileptic drugs on the physical working capacity of ratsShishmanova, M. / Georgieva, K. / Peychev, L. et al. | 2013
- S224
-
P.1.g.060 The effect of mesenchymal stem cells on allodynia, electrophysiologic and histologic parameters in an experimental neuropathy modelAksu, F. / Ergürhan Kiroglu, O. / Yegani, A. A. / Maytalman, E. / Emre, M. / Zorludemir, S. / Mete, S. et al. | 2013
- S225
-
P.1.g.062 Reduction in serotonin 5-HT2C receptor antagonist-induced effects on theta power after chronic escitalopram treatment in ratsKostyalik, D. / Kátai, Z. / Vas, S. Z. / Pap, D. / Horváth, B. / Gyertyán, I. / Tóthfalusi, L. / Bagdy, G. Y. et al. | 2013
- S226
-
P.1.g.063 Inhibition of neuronal nitric oxide synthase in the prelimbic cortex prevents the panic-like reaction organised by medial hypothalamusDe Freitas, R. L. / Hallak, J. E. / Crippa, J. A. / Coimbra, N. C. et al. | 2013
- S227
-
P.1.g.065 Involvement of M2 muscarinic receptors of locus coeruleus in post-ictal antinociceptionPaschoalin Maurin, T. / De Oliveira, R. C. / Coimbra, N. C. et al. | 2013
- S229
-
P.1.g.068 CB1 endocannabinoid receptors of inferior colliculus modulate the catalepsy induced by haloperidol in rodentsDe Medeiros, P. / De Freitas, R. / Coimbra, N. C. / Melo-Thomas, L. et al. | 2013
- S231
-
P.1.g.071 Possible benefits of a combination of physical activity and levodopa administration in a rat model of Parkinson-like diseaseCustodio, C. S. / Santos, J. V. / Gomes, A. C. / Cordeiro, R. C. / Monte, A. S. / Mello, B. S. / Ribeiro, B. M. / Belchior, L. D. / Macedo, D. S. et al. | 2013
- S232
-
P.1.g.073 Modulation of 5-HT-Ach interactions in the hippocampus by newly synthesised peptidomimetics in an experimental model of aggression in ratsKlisurov, R. / Encheva, E. / Tancheva, L. / Shikova, L. / Alova, L. / Kaneva, M. / Tsekova, D. et al. | 2013
- S233
-
P.1.g.074 Plasma concentrations of paroxetine among treatment responder inpatients at week one and before dischargeEryilmaz, G. / Ceylan, M. E. / Unsalver, B. O. / Gogcegoz, I. / Ozilhan, S. / Saglam, E. et al. | 2013
- S234
-
P.1.g.076 Determination of the immunoexpression of iNOS in the hippocampus of rats submitted to the Poly I:C-induced model of schizophreniaRibeiro, B. M. / Mello, B. S. / Custodio, C. S. / Gomes, P. X. / Carmo, M. R. / Vale, M. L. / Menezes, A. T. / Lucena, D. F. / Vasconcelos, S. M. / Macedo, D. S. et al. | 2013
- S235
-
P.1.g.078 Approaches to create dietary supplements to prevent postpartum depressionDowlati, Y. / Ravindran, A. / Segal, Z. / Steiner, M. / Meyer, J. H. et al. | 2013
- S237
-
P.1.g.081 Zinc depletion impairs behaviour and alters trace elements profile in serum and brain structuresDoboszewska, U. / Ostachowicz, B. / Szewczyk, B. / Nowak, G. et al. | 2013
- S238
-
P.1.g.083 Determination of the alterations in prepulse inhibition in mice treated with doxycycline in an animal model of depressionMello, B. S. / Custodio, C. S. / Ribeiro, B. M. / Cordeiro, R. C. / Santos, J. V. / Gomes, P. X. / Sousa, F. C. / Nobre, H. V. / Carvalho, A. F. / Macedo, D. S. et al. | 2013
- S239
-
P.1.g.084 Prevention of nicotine-induced kindling in female periadolescent rats by the repeated administration of N-acetylcysteineCustodio, C. / Mello, B. S. / Costa, A. M. / Gomes, P. X. / Oliveira, G. V. / Araujo, F. Y. / Sousa, F. C. / Carvalho, A. F. / Macedo, D. S. et al. | 2013
- S240
-
P.1.g.086 The formation of serotonin from 5-methoxytryptamine via cytochrome P450 in the brain in vivo – a microdialysis studyBromek, E. / Haduch, A. / Golembiowska, K. / Daniel, W. A. et al. | 2013
- S242
-
P.1.g.089 Demographic evaluation of patients treated with transcranial direct current stimulation (TDCS) in a university hospitalEryilmaz, G. / Unsalver, B. O. / Gogcegoz, G. / Saglam, E. et al. | 2013
- S243
-
P.1.h.002 Chronic effects of a benzodiazepine site inverse agonist on rat behavior in the forced swim test: a comparison with fluoxetineSamardzic, J. / Obradovic, D. I. et al. | 2013
- S245
-
P.1.h.005 Extended effects of chronic social stress on the behaviors of adolescents in adulthoodKovalenko, I. L. / Smagin, D. A. / Galyamina, A. G. / Kudryavtseva, N. N. / Enikolopov, G. N. et al. | 2013
- S246
-
P.1.h.007 Blockade of 5-HT1A receptor corrects anxiety-like behaviour in gonadectomized male rats of middle age treated with low dose of testosteroneFedotova, J. et al. | 2013
- S247
-
P.1.h.009 A2a adenosine receptors as therapeutic targets in schizophrenia: behavioural characterisation of A2a knockout miceMoscoso-Castro, M. / Gracia-Rubio, I. / Ruiz-Medina, J. / Valverde, O. et al. | 2013
- S248
-
P.1.h.011 Studies on the effects of some Bidens tripartita extracts on psychomotor abilities in ratsSandu, R. B. / Lupusoru, C. E. / Lupusoru, R. V. / Tartau, L. et al. | 2013
- S249
-
P.1.h.012 Changes in alpha(1D)-adrenergic receptor expression and working memory of female mice with selective glucocorticoid receptor ablationChmielarz, P. / Kreiner, G. / Zelek-Molik, A. / Nalepa, I. et al. | 2013
- S250
-
P.1.h.014 The effects of mitochondrial mediators on spontaneous activity and balanceAlexa, T. / Dondas, A. / Luca, A. / Negru, A. / Stanciuc, I. / Gherca, C. E. / Mihai, A. / Bohotin, C. R. et al. | 2013
- S252
-
P.1.h.017 Regulation of the level of LSAMP gene and protein by alternative promoters in mouse brain and implications in behavioral modelsPhilips, M. / Lilleväli, K. / Innos, J. / Luuk, H. / Hundahl, C. A. / Heinla, I. / Vasar, E. et al. | 2013
- S253
-
P.1.h.019 Different patterns of c-fos expression in conditioned place aversion induced by haloperidol or by social transfer in miceFukushiro, D. F. / Aramini, T. C. / Uehara, R. A. / Frussa-Filho, R. et al. | 2013
- S254
-
P.1.h.021 Sequential structure of agonistic behaviour is modified after paramethoxyamphetamine (PMA) administration in male miceMuela, A. T. / Martín-López, M. / Cavas, M. / Navarro, J. F. et al. | 2013
- S255
-
P.1.h.022 Role of monoaminergic receptors in the panic-like behaviour evoked in Swiss mice by confrontation with wild coral snakesDe Freitas, R. L. / Rimi, L. V. / Biagioni, A. F. / Ubiali, W. A. / Coimbra, N. C. et al. | 2013
- S256
-
P.1.h.024 3,4-Methylenedioxyethylamphetamine (MDEA) provokes changes in the sequential structure of the agonistic behaviour of miceMuela, A. T. / Martm-López, M. / Cavas, M. / Navarro, J. F. et al. | 2013
- S257
-
P.1.h.026 Effects of obestatin and its fragment (1–4) on algesthesia and behavioural activity in male wistar ratsKhirazova, E. / Maslova, M. / Guseva, A. / Graf, A. / Maklakova, A. / Sokolova, N. / Kamenskij, A. / Bespalova, Z. / Frid, D. et al. | 2013
- S259
-
P.1.h.029 MK-801-induced hyperlocomotion in rats is affected by modulation of α5-containing GABAA receptorsTimic, T. / Joksimovic, S. / Obradovic, A. L. / Poe, M. M. / Biawat, P. / Ramerstorfer, J. / Roth, B. L. / Sieghart, W. / Cook, J. M. / Savic, M. M. et al. | 2013
- S260
-
P.1.h.031 The effects of intrathecal versus intraperitoneal vitamin C administration on pain models in miceLuca, A. / Alexa, T. / Dondas, A. / Andron, G. D. / Negru, D. / Bohotin, C. R. et al. | 2013
- S262
-
P.1.i.002 Subgenual anterior cingulate cortical functional connectivity in treatment-resistant depressionBaeken, C. / Marinazzo, D. / Wu, G. R. / Van Schuerbeek, P. / De Mey, J. / De Raedt, R. et al. | 2013
- S263
-
P.1.i.003 PET brain imaging of neuropeptide Y2 receptorsSmith, D. / Winterdahl, M. / Audrain, H. / Landau, A. / Bonaventure, P. / Shoblock, J. / Carruthers, N. / Swanson, D. / Bender, D. et al. | 2013
- S264
-
P.1.i.005 Acute neural effects of SSRIs versus NRIs on emotion processing: implications for differential treatment efficacyOuthred, T. / Hawkshead, B. E. / Wager, T. D. / Das, P. / Malhi, G. S. / Kemp, A. H. et al. | 2013
- S265
-
P.1.i.006 Brain sonography as a novel method for detection of nuclei raphe lesion in suicidal patients and MDMA usersBudisic, M. / Karlovic, D. / Buljan, D. / Strineka, M. / Basic-Kes, V. et al. | 2013
- S266
-
P.1.i.008 Bipolar disorder and magnetic resonance imagingGuillena, S. L. / Valseca, P. A. / Casado, P. V. / Henche, E. G. / de Diego, B. O. et al. | 2013
- S267
-
P.1.i.009 Default mode network alterations in refractory schizophrenia patients with auditory verbal hallucinationsAlonso-Solis, A. / Vives-Gilabert, Y. / Grasa, E. M. / Durán-Sindreu, S. / Keymer, A. / Roldan, A. / Nuñez-Marín, F. / Gómez-Ansón, B. / Perez, V. / Corripio, I. et al. | 2013
- S268
-
P.1.i.011 Prefrontal serotonin transporter binding is not associated with trait aggression and impulsivity in healthy subjectsDa Cunha-Bang, S. / Frokjaer, V. / McMahon, B. / Holst, K. / Jensen, P. / Moos Knudsen, G. et al. | 2013
- S269
-
P.1.i.012 Habenular nuclei in different phases of major depressive disorder: a magnetic resonance imaging volumetric studyCarceller, M. / Serra-Blasco, M. / De Diego-Adeliño, J. / Vives-Gilabert, Y. / Gómez-Anson, B. / Puigdemont, D. / Álvarez, E. / Pérez, V. / Portella, M. et al. | 2013
- S270
-
P.1.i.014 Alterations of white matter microstructure in anorexia nervosaVia, E. / Zalesky, A. / Fornito, A. / García, I. / Forcano, L. / Pujol, J. / Fernández-Aranda, F. / Menchón, J. M. / Soriano-Mas, C. / Cardoner, N. et al. | 2013
- S271
-
P.1.i.015 The effect of the brain-derived neurotrophic factor Val66Met polymorphism on human hippocampal volume – a meta-analysisHarrisberger, F. / Smieskova, R. / Schmidt, A. / Papassotiropoulos, A. / Borgwardt, S. et al. | 2013
- S272
-
P.1.i.017 Three week bright-light intervention has dose-related effects on threat-related corticolimbic reactivity and functional couplingFisher, P. M. / Madsen, M. K. / Mc Mahon, B. / Holst, K. K. / Andersen, S. B. / Laursen, H. R. / Hasholt, L. F. / Siebner, H. R. / Knudsen, G. M. et al. | 2013
- S273
-
P.1.i.018 Anterior cingulate cortex reactivity to emotion processing in premenstrual disphoric disorderComasco, E. / Hahn, A. / Ganger, S. / Gingnell, M. / Bannbers, E. / Oreland, L. / Wikström, J. / Lanzenberger, R. / Sundström-Poromaa, I. et al. | 2013
- S274
-
P.1.i.020 Grey matter volume abnormalities in adolescents at high risk for psychosisSugranyes, G. / De la Serna, E. / Espelt, C. / Calvo, A. / Sanchez-Gistau, V. / Puig, O. / Romero, S. / Dolz, M. / Castro-Fornieles, J. / Baeza, I. et al. | 2013
- S275
-
P.1.i.021 Chronic cannabinoid treatment induces connectivity alterations in the juvenile rat brain evidenced by diffusion tensor imagingHumbert-Claude, M. / Larrat, B. / Tanter, M. / Lenkei, Z. et al. | 2013
- S276
-
P.1.i.023 White matter abnormalities in children and adolescents with autism spectrum disorder and in their unaffected siblings: a diffusion tensor imaging studyRosa, M. / Puig, O. / Calvo, A. / Bargalló, N. / Calvo, R. M. et al. | 2013
- S277
-
P.1.i.025 Abnormal brain functioning during salience processing in patients with schizophrenic psychosisWalter, A. / Smieskova, R. / Schmidt, A. / Simon, A. / Vogel, T. / Roiser, J. P. / Riecher-Rössler, A. / Borgwardt, S. et al. | 2013
- S278
-
P.1.i.026 Cortical thickness differences in methamphetamine dependent individuals with and without a history of psychosisUhlmann, A. / Koen, N. / Sinclair, H. / Temmingh, H. / Meintjes, E. / Stein, D. J. et al. | 2013
- S279
-
P.1.i.028 Emotion processing in eating disorders: an fMRI studyMolina-Ruiz, R. M. / Marina Díaz-Marsá, M. / Tomás García Saiz, T. / Esther Via, E. / Helena Trebbau, H. / Mariano Rincón, M. et al. | 2013
- S281
-
P.1.j.001 Cognitive function in recovered geriatric depressive patientsKim, B. / Chang, J. / Lee, D. / Park, J. et al. | 2013
- S282
-
P.1.j.003 Abnormal reward processing in the methylazoxymethanol (MAM) model of schizophrenia: neural and behavioural evidenceFrancois, J. / Conway, M. / Huxter, J. / Lowry, J. P. / Tricklebank, M. / Gilmour, G. et al. | 2013
- S284
-
P.1.j.006 Association between cognitive function and patient-reported depression severity among patients treated for depressionAkhras, K. S. / Samp, J. C. / Kurlander, J. L. / Walker, V. / Kingery, L. R. / Jaeger, J. / Maruff, P. et al. | 2013
- S285
-
P.1.j.008 Computerised cognitive testing in the medical treatment of neurological and psychiatric disordersKurzbuch, K. / Graf, W. / Kasper, B. S. / Stefan, H. / Pauli, E. et al. | 2013
- S287
-
P.1.j.011 Synthesis and pharmacological evaluation of irreversible allosteric ligands for the M1 muscarinic acetylcholine receptorDavie, B. J. / Valant, C. / Capuano, B. / Scammells, P. J. / Christopoulos, A. et al. | 2013
- S288
-
P.1.j.013 Pharmacological characterisation and phase I evaluation in healthy volunteers of the nAChR agonist, AQW051Lopez, C. L. / Johns, D. / Weiss, M. / Feuerbach, D. et al. | 2013
- S290
-
P.1.j.016 Adulthood isolation stress enhances both long- and short-term potentiation in ratsTan, B. / Deneme, F. / Bitiktas, S. / Kavraal, S. / Ascioglu, M. / Suer, C. et al. | 2013
- S291
-
P.1.j.018 Deletion of cannabinoid-2 receptors induces memory impairment associated with synaptic plasticity alterationsGarcía-Gutiérrez, M. / Ortega-Alvaro, A. / Busquets, A. / Péirez-Ortiz, J. M. / Caltana, L. / Ricatti, M. J. / Brusco, A. / Maldonado, R. / Manzanares, J. et al. | 2013
- S292
-
P.1.j.019 Cognitive deficit in myotonic dystrophy type 1Park, Y. G. / Kim, S. M. / Choi, Y. C. et al. | 2013
- S293
-
P.1.j.021 Cognitive abilities are changed in gamma-synuclein knockout miceKokhan, V. / Vankin, G. / Shamakina, I. et al. | 2013
- S295
-
P.1.j.024 Theory of mind deficit in bipolar patients with subsyndromal illnessSimon, M. / Herold, R. / Hajnal, A. S. / Varga, E. / Fekete, S. / Tényi, T. et al. | 2013
- S296
-
P.1.j.026 Cognitive deficits caused by hippocampal disinhibition: attentional and memory deficitsMcGarrity, S. / Kevin, K. C. / Mason, R. / Pezze, M. A. / Bast, T. et al. | 2013
- S297
-
P.1.j.028 Dissecting reward processing in the brain: a human experimental model for biomarker discovery in major depressive disorderMcCabe, C. et al. | 2013
- S299
-
P.1.k.002 Epidemiological 3-year follow-up study on vascular depression in an elderly Korean populationPark, J. H. / Kim, T. H. / Yoo, B. I. / Han, J. W. / Kim, K. W. et al. | 2013
- S300
-
P.1.k.004 Sociodemographic and clinical characteristics of involuntary admissions in patients with schizophrenia and bipolar disorderGuillena, S. L. / de Diego, B. O. / Barquero, N. C. / García-Largo, L. M. et al. | 2013
- S301
-
P.1.k.005 Co-morbidity between epilepsy and severe psychiatric illness: a population-based studyKapara, O. / Feruchter, E. / Reichenberg, A. / Yoffe, R. / Fono-Yetiv, O. / Kreiss, I. / Davidson, M. / Weiser, M. et al. | 2013
- S302
-
P.1.k.007 Prevalence and related risk factors of suicidal ideation of adolescents in an urban areaCho, S. J. / Lee, T. H. / Lee, Y. J. / Kim, S. J. / Oh, K. S. et al. | 2013
- S303
-
P.1.k.009 Care programme approach: is there a difference in treatment perceived by service usersChakraborty, N. / Ahmed, S. et al. | 2013
- S305
-
P.1.k.012 Detecting domestic violence: the use of revised Conflict Tactics Scale (CTS-2) in ItalyArcidiacono, E. / Signorelli, M. S. / Aguglia, E. et al. | 2013
- S306
-
P.1.k.013 Mental health of single fathers and single mothers in single parent families living in an urban community in South KoreaKim, S. I. / Kim, E. J. et al. | 2013
- S307
-
P.1.k.015 Bayesian tools for optimizing adaptive clinical trialsSiu, C. / Brambilla, C. / Ruggeri, F. et al. | 2013
- S308
-
P.2.a.002 Stressful experience during peri-adolescent period induces depression-like phenotype in adult mouseLo Iacono, L. / Comandini, F. V. / Puglisi-Allegra, S. / Carola, V. et al. | 2013
- S309
-
P.2.a.003 Antidepressant-like effect of NOP receptor antagonist BAN ORL 24Twardowschy, A. / Andreatini, R. / Coimbra, N. C. et al. | 2013
- S310
-
P.2.a.005 Antidepressant-like effect of 1,2,3,4-tetrahydroisoquinoline in forced swim test in comparison to citalopramMozdzen, E. / Michaluk, J. / Wasik, A. / Romanska, I. / Antkiewicz-Michaluk, L. et al. | 2013
- S312
-
P.2.a.008 Role of melatonin, 5-HT2B, and 5-HT2C receptors in modulating the firing activity of rat dopamine neuronsEl Mansari, M. / Chenu, F. / Blier, P. et al. | 2013
- S313
-
P.2.a.010 Serotonin transporter-siRNA rapidly exerts antidepressant effects following internalisation into serotonergic neuronsFerres-Coy, A. / Pilar-Cuellar, F. / Vidal, R. / Galofré, M. / Paz, V. / Campa, L. / Montefeltro, A. / Valdizan, E. M. / Artigas, F. / Bortolozzi, A. et al. | 2013
- S314
-
P.2.a.011 Chronic mild stress-induced behavioural and epigenetic changes in mice – prevention by agomelatine treatmentBoulle, F. / Massart, R. / Zaidan, L. / Marday, S. / Gabriel, C. / Mocaër, E. / Hamon, M. / Lanfumey, L. et al. | 2013
- S315
-
P.2.a.013 Antidepressant treatment and prefrontal cortex-hippocampus connection inhibition: communicating vessels?Kafetzopoulos, V. / Kokras, N. / Vassalou, A. / Antoniou, K. / Papadopoulou-Daifoti, Z. / Dalla, C. et al. | 2013
- S317
-
P.2.a.016 Electrode implantation produces an early response to deep brain stimulation in depression: potential role of regional neuroinflammationPerez-Caballero, L. / Perez-Egea, R. / Puigdemont, D. / Romero-Grimaldi, C. / Molet, J. / Caso, J. R. / Mico, J. A. / Pérez, V. / Leza, J. C. / Berrocoso, E. et al. | 2013
- S318
-
P.2.b.001 Cognitive functioning after deep brain stimulation in subcallosal cingulate gyrus for treatment-resistant depressionSerra-Blasco, M. / De Vita, S. / Rivas, M. / De Diego, J. / Puigdemont, D. / Martin-Blanco, A. / Alvarez, E. / Pérez, V. / Portella, M. J. et al. | 2013
- S319
-
P.2.b.002 Comparative analysis of agomelatine and trazodone in late-onset major depressionVasile, D. / Vasiliu, O. / Tudor, C. / Mangalagiu, A. G. / Magazin, O. / Sopterean, G. A. / Bratu, R. E. et al. | 2013
- S320
-
P.2.b.004 Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: tianeptine versus escitalopramJeon, H. J. / Woo, J. M. / Lee, S. H. / Kim, E. J. / Chung, S. H. / Ha, J. H. / Fava, M. / Mischoulon, D. / Kim, J. H. / Yu, B. H. et al. | 2013
- S321
-
P.2.b.005 Psychopharmacological treatment of patients with schizoaffective disorder in comparison to schizophrenia and bipolar disorderAssion, H. J. / Schweppe, A. / Skiba, M. / Juckel, G. et al. | 2013
- S322
-
P.2.b.007 Efficacy and tolerability of bupropion in major depressive disorder associated with Parkinsons diseaseVasile, D. / Macovei, R. A. / Vasiliu, O. et al. | 2013
- S323
-
P.2.b.009 Abnormality of white matter structure and resting state brain function in drug naive patients with major depressive disorderHuang, M. L. / Yu, L. / Wei, N. / Hu, J. B. / Lou, B. Y. / Xu, Y. et al. | 2013
- S324
-
P.2.b.010 Genetic predictor of antidepressant response for major depressive disorder: a genome-wide association study and pathway analysisNakano, W. / Mehta, D. / Ising, M. / Pfister, H. / Czamara, D. / Holsboer, F. / Lucae, S. / Erhardt-Lehmann, A. / Binder, E. B. et al. | 2013
- S325
-
P.2.b.012 Vilazodone improves anxiety symptoms in patients with major depressive disorder: a pooled analysis of efficacyEdwards, J. / Chen, D. / Ruth, A. / Thase, M. E. et al. | 2013
- S327
-
P.2.b.015 iNOS gene expression correlates with cognitive impairment in recurrent depressive disorderTalarowska, M. / Galecki, P. et al. | 2013
- S328
-
P.2.b.017 Distribution pattern of activity shifts in accordance with improvement of depressive symptoms in patients with depressive episodeNoh, J. / Yoo, S. / Lee, E. / Kwon, Y. / An, N. / Lee, J. / Park, J. / Chung, Y. K. et al. | 2013
- S329
-
P.2.b.019 Clock gene polymorphisms and haplotypes in mood disorder in a Polish cohortWilkosc, M. / Wegalrz, M. / Maciukiewicz, M. / Pawlak, J. / Leszczynska-Rodziewicz, A. / Hauser, J. et al. | 2013
- S331
-
P.2.b.022 Worsening conditions for the depressive mental states with aging in Japanese patients with subacute myelo-optico-neuropathy (SMON)Konishi, T. / Hayashi, K. / Fujita, M. et al. | 2013
- S332
-
P.2.b.024 Efficacy of antidepressants in the treatment of major depressive disorder: a naturalistic studyBalagué Anó, A. / Ollés, M. V. / Gento, P. / Turnes, E. / Calvo, J. et al. | 2013
- S334
-
P.2.b.027 A phase II randomized, double-blind, placebo-controlled trial of GLYX-13 for the rapid treatment of major depressive disorder (MDD) using central ratingsPopp, D. / Burch, R. / Williams, J. B. / Price, L. M. / Detke, M. J. et al. | 2013
- S336
-
P.2.b.030 Levomilnacipran SR and functional efficacy in major depressive disorder: pooled analyses of 5 double-blind, placebo-controlled trialsSambunaris, A. / Gommoll, C. / Chen, C. / Greenberg, W. M. et al. | 2013
- S337
-
P.2.b.032 Neural correlates of emotion regulation response to negative stimuli in young women at high risk for depressionSimsek, F. / Oguz, K. A. / Akan, S. / Haznedaroglu Isman, D. / Acikel, D. / Kitis, O. M. / Cetinkalp, S. / Eker, M. / Coburn, K. / Gonul, A. et al. | 2013
- S339
-
P.2.b.035 Metabolic syndrome and C-reactive protein in patients with depressive disorder on antidepressive medicationPopovic, I. / Ravanic, D. / Stanojevic, A. / Popovic, V. / Vladejic, S. et al. | 2013
- S341
-
P.2.b.038 How to switch to agomelatine after an initial treatment failure of paroxetine or venlafaxine?Lejoyeux, M. / Picarel-Blanchot, F. / De Bodinat, C. et al. | 2013
- S342
-
P.2.b.040 Inflame-Beat: insufficient glucocorticoid signalling and inflammatory activation in coronary heart disease patients with depressionCarvalho, L. A. / Nikkheslat, N. / Pariante, C. M. et al. | 2013
- S343
-
P.2.b.042 Escitalopram effectiveness in depressed patients suffering from neurological disorders – data from an open label study in GreeceSakka, P. / Papalexi, E. / Chourdaki, E. / Skamnelos, C. / Parashos, I. A. et al. | 2013
- S344
-
P.2.b.043 Glucocorticoid receptors, serotonin and dopamine neurotransmission are associated with interferon-induced depressionUdina, M. / Navinés, R. / Grande, I. / Nardi, A. E. / Langohr, K. / Gratacòs, M. / Vieta, E. / Valdés, M. / Solà, R. / Martín-Santos, R. et al. | 2013
- S345
-
P.2.b.045 Treatment of major depression reduces arterial stiffnessKokras, N. / Kouzoupis, A. V. / Papamichael, C. / Papadimitriou, G. N. / Stamatelopoulos, K. S. et al. | 2013
- S346
-
P.2.b.046 Effects of metabolic syndrome on the treatment response of in-patients with major depressive disorderJung, H. / Lee, S. / Kim, S. / Na, K. / Lee, B. et al. | 2013
- S347
-
P.2.b.048 Functional impairment in major depressive disorder: preliminary findings of the PERFORM studySaragoussi, D. / Haro, J. M. / Boulenger, J. P. / Lamy, F. X. / Di Nicola, S. / Rive, B. et al. | 2013
- S348
-
P.2.b.050 Mineralocorticoid receptor function a predictor of treatment response in depression with or without early life stressJuruena, M. F. / Moreira, A. C. / Castro, M. / Graeff, F. G. et al. | 2013
- S349
-
P.2.b.051 Cognitive impairment and decreased quality of life in elderly patients with subsyndromal depressionLee, C. I. / Ryu, J. S. / Kim, M. D. / Park, J. H. et al. | 2013
- S350
-
P.2.b.053 Treatment adherence in recurrent depression and self-esteem: a correlation studyRadu, M. / Paziuc, L. / Chirita, R. et al. | 2013
- S351
-
P.2.b.055 Suicide intent is associated with temporally proximal insomnia and short sleep duration independently of current major depressionFerentinos, P. / Christodoulou, C. / Porichi, E. / Lykouras, L. / Liappas, I. et al. | 2013
- S353
-
P.2.b.058 The relevance of oxidative stress status in first episode and recurrent depressionPadurariu, M. / Ciobica, A. / Stefanescu, C. et al. | 2013
- S354
-
P.2.b.060 Language phenomenon in the diagnostic criteria of mild depressionSmirnova, D. / Sloeva, E. / Kuvshinova, N. / Krasnov, A. / Ustinov, M. / Romanov, D. / Nosachev, G. et al. | 2013
- S355
-
P.2.c.001 Mood disorder and obesity: policy and evidence revisitedSchmidt, A. E. / Reininghaus, E. Z. et al. | 2013
- S356
-
P.2.c.003 Subjective Well-being under Neuroleptic Scale in outpatients with bipolar disorderGuillena, S. L. / Gotor, F. / Santamaria, O. et al. | 2013
- S357
-
P.2.c.005 Myricitrin, a PKC inhibitor, exerts antimanic-like effects in animal modelsAndreatini, R. / Pereira, M. / Siba, I. P. / Pizzolatti, M. G. / Santos, A. R. / Ruani, A. P. et al. | 2013
- S358
-
P.2.c.006 The role of tetraspanin 8 in bipolar disorderSchartner, C. / Scholz, C. J. / Weber, H. / Weißflog, L. / Reif, A. et al. | 2013
- S359
-
P.2.c.008 Increased mitochondrial lipid peroxidation in depression bipolar episodeJornada, L. / Steckert, A. / Scussel, F. / Ferreira, G. / Streck, E. / Ferrari, P. / Pfaffenseller, B. / Costanzi, M. / Czepielewski, L. / Quevedo, J. et al. | 2013
- S360
-
P.2.c.011 Overexpression of the homeobox Otx2 gene leads to spontaneous fluctuations in manic- and depressive-like behaviourJukic, M. / Avin, A. / Bar, M. / Baron, T. / Zega, K. / Novikov, O. / Kofman, O. / Agam, G. / Brodski, C. et al. | 2013
- S361
-
P.2.c.012 Evaluation of peripheral biomarkers in bipolar and unipolar depressionSchilling Panizzutti, B. / Wollenhaupt-Aguiar, B. / Pfaffenseller, B. / Spanemberg, L. / Caldieraro, M. A. / Vares, E. A. / Fleck, M. P. / Kunz, M. / Kapczinski, F. / Kauer-SantAnna, M. et al. | 2013
- S362
-
P.2.d.001 Neurocognitive impairments in bipolar disorder are restricted to a subgroup of patientsSparding, T. / Silander, K. / Hansen, S. / Landén, M. et al. | 2013
- S363
-
P.2.d.003 Fractional anisotropy in patients with first episode mania in late lifeRamirez-Bermudez, J. / Alvarado, P. / Marrufo, O. / Berlanga, C. / Guadamuz, A. / Atriano, C. / Carrillo, R. / Taboada, J. / Perez-Esparza, R. et al. | 2013
- S364
-
P.2.d.004 Increased insulin-like growth factor-1 in manic patients with bipolar I disorderKim, Y. K. / Na, C. / Han, S. W. / Na, K. S. et al. | 2013
- S365
-
P.2.d.006 The MANACOR study on treatment effectiveness in maniaCruz Culebra, N. / Saez, C. / Mur, M. / Nieto, E. / Vieta, E. et al. | 2013
- S366
-
P.2.d.007 Are comorbid insulin resistance and type II diabetes risk factors for refractory bipolar illness?Calkin, C. / Ruzickova, M. / Slaney, C. / Garnham, J. / Ransom, T. / Alda, M. et al. | 2013
- S367
-
P.2.d.009 The predictive role of Val66Met polymorphism on levels of BDNF along treatment of medication-free patients with bipolar disorderGrande, I. / Magalhães, P. / Chendo, I. / Sterzt, L. / Fries, G. / Cereser, K. / Kunz, M. / Frey, B. / Vieta, E. / Kapczinski, F. et al. | 2013
- S368
-
P.2.d.010 Breaking bad news – a valproate reauditAtturu, H. / Odelola, D. / Etuk, E. / Harris, S. et al. | 2013
- S369
-
P.2.d.012 Clinical implications of the polarity index of drugs in maintenance treatment of bipolar disorder: a naturalistic studyPopovic, D. / Torrent, C. / Bonnin, C. M. / Nivoli, A. M. / Murru, A. / Pacchiarotti, I. / Valenti, M. / Vieta, E. et al. | 2013
- S370
-
P.2.d.014 Genetic variability at IMPA2 and INPP1 genes is associated to lithium response in bipolar patientsJimenez, E. / Arias, B. / Mitjans, M. / Goikolea, J. M. / Saiz, P. A. / Garcia-Portilla, M. P. / Buron, P. / Bobes, J. / Vieta, E. / Benabarre, A. et al. | 2013
- S371
-
P.2.d.015 Cognitive deficits in obese bipolar patients – the impact of body fat distributionLackner, N. / Bengesser, S. / Birner, A. / Reininghaus, B. / Kattnig, F. / Fellendorf, F. T. / Mitteregger, A. / Oberreither, E. / Wallner-Liebmann, S. J. / Kapfhammer, H. P. et al. | 2013
- S372
-
P.2.d.017 Is hyperthymic temperament an alarming sign?Marinova, P. / Hranov, L. G. et al. | 2013
- S373
-
P.2.d.018 Initial and post-treatment serum levels of total oxidant-antioxidant status and oxidative stress index in patients with manic episodeKalelioglu, T. / Genc, A. / Tasdemir, A. / Karamustafalioglu, N. / Gungor, F. C. / Cansiz, A. / Incir, S. / Emul, M. / Ilnem, M. C. et al. | 2013
- S374
-
P.2.d.020 The effectiveness of asenapine in clinical practice: the EXPASEN studyMurru, A. / Cruz, N. / Gonzalez-Pinto, A. / De Dios, C. / Montes, J. M. / Perez, A. / Zorrilla, I. / Lopez, P. / Vieta, E. et al. | 2013
- S375
-
P.2.d.022 Cariprazine effects on YMRS items: results of a pooled analysis of 3 randomized, double-blind, placebo-controlled trials in bipolar maniaKeck, P. / Zukin, S. / Lu, K. / Ruth, A. / Laszlovszky, I. / Nemeth, G. / Durg am, S. et al. | 2013
- S376
-
P.2.d.023 Associations between cerebrospinal fluid markers and on-going medical treatment in patients with bipolar disorderJakobsson, J. / Pålsson, E. / Bjerke, M. / Olsson, B. / Ekman, C. J. / Sellgren, C. / Johansson, A. G. / Blennow, K. / Zetterberg, H. / Landén, M. et al. | 2013
- S378
-
P.2.d.026 Efficacy and safety of low- and high-dose cariprazine in patients with acute mania associated with bipolar I disorderCalabrese, J. R. / Keck, P. E. / Starace, A. / Lu, K. / Ruth, A. / Laszlovszky, I. / Nemeth, G. / Durgam, S. et al. | 2013
- S380
-
P.2.d.029 Serum matrix metalloproteinase-9 (MMP-9) and interferon gamma (IFN-γ) in bipolar mood disorderRemlinger-Molenda, A. / Czech-Kucharska, A. / Wojcicka, M. / Michalak, M. / Losy, J. / Rybakowski, J. K. et al. | 2013